CINXE.COM
Improving Outcomes in Rare Disease Trials - Anju
<!doctype html> <html lang="en-US"> <head> <meta charset="UTF-8"> <meta name="viewport" content="width=device-width, initial-scale=1"> <link rel="profile" href="https://gmpg.org/xfn/11"> <!-- Favicons --> <!-- <link rel="apple-touch-icon" sizes="180x180" href="https://www.anjusoftware.com/wp-content/themes/bootscore-child-main/img/favicon/apple-touch-icon.png"> <link rel="icon" type="image/png" sizes="32x32" href="https://www.anjusoftware.com/wp-content/themes/bootscore-child-main/assets/images/favicon.png"> <link rel="icon" type="image/png" sizes="16x16" href="https://www.anjusoftware.com/wp-content/themes/bootscore-child-main/assets/images/favicon.png"> <link rel="manifest" href="https://www.anjusoftware.com/wp-content/themes/bootscore-child-main/assets/images/site.webmanifest" crossorigin="use-credentials"> <link rel="mask-icon" href="https://www.anjusoftware.com/wp-content/themes/bootscore-child-main/img/favicon/safari-pinned-tab.svg" color="#0d6efd"> --> <meta name="msapplication-TileColor" content="#ffffff"> <meta name="theme-color" content="#ffffff"> <!-- Google Tag Manager --> <script> (function(w, d, s, l, i) { w[l] = w[l] || []; w[l].push({ 'gtm.start': new Date().getTime(), event: 'gtm.js' }); var f = d.getElementsByTagName(s)[0], j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src = 'https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f); })(window, document, 'script', 'dataLayer', 'GTM-WWQHZDD7'); </script> <!-- End Google Tag Manager --> <meta name='robots' content='index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1' /> <!-- Start VWO Common Smartcode --> <script data-cfasync="false" nowprocket type='text/javascript'> var _vwo_clicks = 10; </script> <!-- End VWO Common Smartcode --> <!-- Start VWO Async SmartCode --> <link rel="preconnect" href="https://dev.visualwebsiteoptimizer.com" /> <script data-cfasync="false" nowprocket type='text/javascript' id='vwoCode'> /* Fix: wp-rocket (application/ld+json) */ window._vwo_code || (function () { var account_id=924355, // replace 1 with ${accountId} in release string version=2.1, settings_tolerance=2000, library_tolerance=2500, use_existing_jquery=false, hide_element='body', hide_element_style = 'opacity:0 !important;filter:alpha(opacity=0) !important;background:none !important;transition:none !important;', /* DO NOT EDIT BELOW THIS LINE */ f=false,w=window,d=document,v=d.querySelector('#vwoCode'),cK='_vwo_'+account_id+'_settings',cc={};try{var c=JSON.parse(localStorage.getItem('_vwo_'+account_id+'_config'));cc=c&&typeof c==='object'?c:{}}catch(e){}var stT=cc.stT==='session'?w.sessionStorage:w.localStorage;code={use_existing_jquery:function(){return typeof use_existing_jquery!=='undefined'?use_existing_jquery:undefined},library_tolerance:function(){return typeof library_tolerance!=='undefined'?library_tolerance:undefined},settings_tolerance:function(){return cc.sT||settings_tolerance},hide_element_style:function(){return'{'+(cc.hES||hide_element_style)+'}'},hide_element:function(){if(performance.getEntriesByName('first-contentful-paint')[0]){return''}return typeof cc.hE==='string'?cc.hE:hide_element},getVersion:function(){return version},finish:function(e){if(!f){f=true;var t=d.getElementById('_vis_opt_path_hides');if(t)t.parentNode.removeChild(t);if(e)(new Image).src='https://dev.visualwebsiteoptimizer.com/ee.gif?a='+account_id+e}},finished:function(){return f},addScript:function(e){var t=d.createElement('script');t.type='text/javascript';if(e.src){t.src=e.src}else{t.text=e.text}d.getElementsByTagName('head')[0].appendChild(t)},load:function(e,t){var i=this.getSettings(),n=d.createElement('script'),r=this;t=t||{};if(i){n.textContent=i;d.getElementsByTagName('head')[0].appendChild(n);if(!w.VWO||VWO.caE){stT.removeItem(cK);r.load(e)}}else{var o=new XMLHttpRequest;o.open('GET',e,true);o.withCredentials=!t.dSC;o.responseType=t.responseType||'text';o.onload=function(){if(t.onloadCb){return t.onloadCb(o,e)}if(o.status===200||o.status===304){_vwo_code.addScript({text:o.responseText})}else{_vwo_code.finish('&e=loading_failure:'+e)}};o.onerror=function(){if(t.onerrorCb){return t.onerrorCb(e)}_vwo_code.finish('&e=loading_failure:'+e)};o.send()}},getSettings:function(){try{var e=stT.getItem(cK);if(!e){return}e=JSON.parse(e);if(Date.now()>e.e){stT.removeItem(cK);return}return e.s}catch(e){return}},init:function(){if(d.URL.indexOf('__vwo_disable__')>-1)return;var e=this.settings_tolerance();w._vwo_settings_timer=setTimeout(function(){_vwo_code.finish();stT.removeItem(cK)},e);var t;if(this.hide_element()!=='body'){t=d.createElement('style');var i=this.hide_element(),n=i?i+this.hide_element_style():'',r=d.getElementsByTagName('head')[0];t.setAttribute('id','_vis_opt_path_hides');v&&t.setAttribute('nonce',v.nonce);t.setAttribute('type','text/css');if(t.styleSheet)t.styleSheet.cssText=n;else t.appendChild(d.createTextNode(n));r.appendChild(t)}else{t=d.getElementsByTagName('head')[0];var n=d.createElement('div');n.style.cssText='z-index: 2147483647 !important;position: fixed !important;left: 0 !important;top: 0 !important;width: 100% !important;height: 100% !important;background: white !important;';n.setAttribute('id','_vis_opt_path_hides');n.classList.add('_vis_hide_layer');t.parentNode.insertBefore(n,t.nextSibling)}var o='https://dev.visualwebsiteoptimizer.com/j.php?a='+account_id+'&u='+encodeURIComponent(d.URL)+'&vn='+version;if(w.location.search.indexOf('_vwo_xhr')!==-1){this.addScript({src:o})}else{this.load(o+'&x=true')}}};w._vwo_code=code;code.init();})(); </script> <!-- End VWO Async SmartCode --> <meta name="be:wp" content="1.1.16"> <!-- be_ixf, sdk, gho--> <meta name="be:sdk" content="php_sdk_1.5.12" /> <meta name="be:timer" content="83ms" /> <meta name="be:orig_url" content="https%3A%2F%2Fwww.anjusoftware.com%2Finsights%2Feclinical%2Fpatient-engagement%2Frare-disease-trial-outcomes%2F" /> <meta name="be:norm_url" content="https%3A%2F%2Fwww.anjusoftware.com%2Finsights%2Feclinical%2Fpatient-engagement%2Frare-disease-trial-outcomes%2F" /> <meta name="be:capsule_url" content="https%3A%2F%2Fixfd1-api.bc0a.com%2Fapi%2Fixf%2F1.0.0%2Fget_capsule%2Ff00000000264232%2F1044965487" /> <meta name="be:api_dt" content="Zy_2023;Zm_04;Zd_21;Zh_19;Zmh_25;p_epoch:1.68210510525E+12" /> <meta name="be:mod_dt" content="Zy_2023;Zm_04;Zd_21;Zh_19;Zmh_25;p_epoch:1.68210510525E+12" /> <meta name="be:diag" content="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" /> <meta name="be:messages" content="true" /> <style> .be-ix-link-block{background-color: #f5f7f8;} .be-ix-link-block .be-related-link-container {padding-top: 25px;} .be-ix-link-block .be-related-link-container .be-label {margin: 0;font-weight: 700;font-size: 18px;line-height: 28px;color: var(--text-blue-900);letter-spacing: -.02em;} .be-ix-link-block .be-related-link-container .be-list { display: inline-block; list-style: none;margin: 0; padding: 0;} .be-ix-link-block .be-related-link-container .be-list .be-list-item {display: inline-block;margin-right: 20px;padding-bottom: 6px;} .be-ix-link-block .be-related-link-container .be-list .be-list-item .be-related-link {font-weight: 400;font-size: 18px;line-height: 28px;letter-spacing: -.02em;color: var(--text-gray-900);text-decoration: none;} .be-ix-link-block .be-related-link-container .be-list .be-list-item .be-related-link:hover {color: var(--text-blue-900);} .be-ix-link-block .be-related-link-container .be-list .be-list-item:last-child { margin-right: 0;} @media (max-width: 767px) { .be-ix-link-block .be-related-link-container .be-label {width: 100%;margin-bottom: 10px;} .be-ix-link-block .be-related-link-container .be-list { display: block;width: 100%;} .be-ix-link-block .be-related-link-container .be-list .be-list-item {display: block;margin-right: 0;} } @media (min-width: 768px) { .be-ix-link-block .be-related-link-container {display: flex;align-items: baseline;justify-content: center; } .be-ix-link-block .be-related-link-container .be-label {display: inline-block;margin-right: 20px;flex-grow: 0;flex-shrink: 0;} } </style> <script> (function() { var bec = document.createElement('script'); bec.type = 'text/javascript'; bec.async = true; bec.setAttribute("data-id", "bec"); bec.setAttribute("org-id", "f00000000264232"); bec.setAttribute("domain", ".anjusoftware.com"); bec.setAttribute("session-timeout", 86400000); bec.src = document.location.protocol + '//cdn.b0e8.com/conv_v3.js'; var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(bec, s); })(); </script> <!-- This site is optimized with the Yoast SEO plugin v23.9 - https://yoast.com/wordpress/plugins/seo/ --> <title>Improving Outcomes in Rare Disease Trials - Anju</title> <meta name="description" content="Explore the outcomes of rare disease trials and the importance of patient engagement in these trials with expert insights from Anju." /> <link rel="canonical" href="https://www.anjusoftware.com/insights/eclinical/patient-engagement/rare-disease-trial-outcomes/" /> <meta property="og:locale" content="en_US" /> <meta property="og:type" content="article" /> <meta property="og:title" content="Improving Outcomes in Rare Disease Trials - Anju" /> <meta property="og:description" content="Explore the outcomes of rare disease trials and the importance of patient engagement in these trials with expert insights from Anju." /> <meta property="og:url" content="https://www.anjusoftware.com/insights/eclinical/patient-engagement/rare-disease-trial-outcomes/" /> <meta property="og:site_name" content="Anju Software" /> <meta property="article:published_time" content="2019-01-29T13:00:17+00:00" /> <meta property="article:modified_time" content="2024-03-25T17:38:51+00:00" /> <meta property="og:image" content="https://www.anjusoftware.com/wp-content/uploads/2023/01/rare-disease-clinical-trials-how-to-improve-participation-and-outcomes.webp" /> <meta property="og:image:width" content="1030" /> <meta property="og:image:height" content="687" /> <meta property="og:image:type" content="image/webp" /> <meta name="author" content="Lisa Pahl" /> <meta name="twitter:card" content="summary_large_image" /> <meta name="twitter:creator" content="@AnjuSoftware" /> <meta name="twitter:site" content="@AnjuSoftware" /> <meta name="twitter:label1" content="Written by" /> <meta name="twitter:data1" content="Lisa Pahl" /> <meta name="twitter:label2" content="Est. reading time" /> <meta name="twitter:data2" content="8 minutes" /> <script type="application/ld+json" class="yoast-schema-graph">{"@context":"https://schema.org","@graph":[{"@type":"Article","@id":"https://www.anjusoftware.com/insights/eclinical/patient-engagement/rare-disease-trial-outcomes/#article","isPartOf":{"@id":"https://www.anjusoftware.com/insights/eclinical/patient-engagement/rare-disease-trial-outcomes/"},"author":{"name":"Lisa Pahl","@id":"https://www.anjusoftware.com/#/schema/person/6de5a0f1282ba2b94340e3f7e9324b6c"},"headline":"Rare Disease Clinical Trials: How to Improve Participation and Outcomes","datePublished":"2019-01-29T13:00:17+00:00","dateModified":"2024-03-25T17:38:51+00:00","mainEntityOfPage":{"@id":"https://www.anjusoftware.com/insights/eclinical/patient-engagement/rare-disease-trial-outcomes/"},"wordCount":1678,"commentCount":0,"publisher":{"@id":"https://www.anjusoftware.com/#organization"},"image":{"@id":"https://www.anjusoftware.com/insights/eclinical/patient-engagement/rare-disease-trial-outcomes/#primaryimage"},"thumbnailUrl":"https://www.anjusoftware.com/wp-content/uploads/2023/01/rare-disease-clinical-trials-how-to-improve-participation-and-outcomes.webp","keywords":["insights"],"articleSection":["eClinical","Insights","Patient Engagement"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https://www.anjusoftware.com/insights/eclinical/patient-engagement/rare-disease-trial-outcomes/#respond"]}]},{"@type":"WebPage","@id":"https://www.anjusoftware.com/insights/eclinical/patient-engagement/rare-disease-trial-outcomes/","url":"https://www.anjusoftware.com/insights/eclinical/patient-engagement/rare-disease-trial-outcomes/","name":"Improving Outcomes in Rare Disease Trials - Anju","isPartOf":{"@id":"https://www.anjusoftware.com/#website"},"primaryImageOfPage":{"@id":"https://www.anjusoftware.com/insights/eclinical/patient-engagement/rare-disease-trial-outcomes/#primaryimage"},"image":{"@id":"https://www.anjusoftware.com/insights/eclinical/patient-engagement/rare-disease-trial-outcomes/#primaryimage"},"thumbnailUrl":"https://www.anjusoftware.com/wp-content/uploads/2023/01/rare-disease-clinical-trials-how-to-improve-participation-and-outcomes.webp","datePublished":"2019-01-29T13:00:17+00:00","dateModified":"2024-03-25T17:38:51+00:00","description":"Explore the outcomes of rare disease trials and the importance of patient engagement in these trials with expert insights from Anju.","breadcrumb":{"@id":"https://www.anjusoftware.com/insights/eclinical/patient-engagement/rare-disease-trial-outcomes/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https://www.anjusoftware.com/insights/eclinical/patient-engagement/rare-disease-trial-outcomes/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https://www.anjusoftware.com/insights/eclinical/patient-engagement/rare-disease-trial-outcomes/#primaryimage","url":"https://www.anjusoftware.com/wp-content/uploads/2023/01/rare-disease-clinical-trials-how-to-improve-participation-and-outcomes.webp","contentUrl":"https://www.anjusoftware.com/wp-content/uploads/2023/01/rare-disease-clinical-trials-how-to-improve-participation-and-outcomes.webp","width":1030,"height":687,"caption":"Rare Disease Clinical Trials"},{"@type":"BreadcrumbList","@id":"https://www.anjusoftware.com/insights/eclinical/patient-engagement/rare-disease-trial-outcomes/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://www.anjusoftware.com/"},{"@type":"ListItem","position":2,"name":"Insights","item":"https://www.anjusoftware.com/insights/"},{"@type":"ListItem","position":3,"name":"Rare Disease Clinical Trials: How to Improve Participation and Outcomes"}]},{"@type":"WebSite","@id":"https://www.anjusoftware.com/#website","url":"https://www.anjusoftware.com/","name":"Anju","description":"Software For Life Sciences","publisher":{"@id":"https://www.anjusoftware.com/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https://www.anjusoftware.com/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https://www.anjusoftware.com/#organization","name":"Anju Software","url":"https://www.anjusoftware.com/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https://www.anjusoftware.com/#/schema/logo/image/","url":"https://www.anjusoftware.com/wp-content/uploads/2024/04/cropped-Anju_Shield_RGB.png","contentUrl":"https://www.anjusoftware.com/wp-content/uploads/2024/04/cropped-Anju_Shield_RGB.png","width":512,"height":512,"caption":"Anju Software"},"image":{"@id":"https://www.anjusoftware.com/#/schema/logo/image/"},"sameAs":["https://x.com/AnjuSoftware"]},{"@type":"Person","@id":"https://www.anjusoftware.com/#/schema/person/6de5a0f1282ba2b94340e3f7e9324b6c","name":"Lisa Pahl","url":"https://www.anjusoftware.com/author/marketinganjusoftware-com/"}]}</script> <!-- / Yoast SEO plugin. --> <link rel='dns-prefetch' href='//ajax.googleapis.com' /> <link rel='dns-prefetch' href='//www.googletagmanager.com' /> <link rel="alternate" type="application/rss+xml" title="Anju Software » Feed" href="https://www.anjusoftware.com/feed/" /> <link rel="alternate" type="application/rss+xml" title="Anju Software » Comments Feed" href="https://www.anjusoftware.com/comments/feed/" /> <link rel="alternate" type="application/rss+xml" title="Anju Software » Rare Disease Clinical Trials: How to Improve Participation and Outcomes Comments Feed" href="https://www.anjusoftware.com/insights/eclinical/patient-engagement/rare-disease-trial-outcomes/feed/" /> <script type="text/javascript"> /* <![CDATA[ */ window._wpemojiSettings = {"baseUrl":"https:\/\/s.w.org\/images\/core\/emoji\/15.0.3\/72x72\/","ext":".png","svgUrl":"https:\/\/s.w.org\/images\/core\/emoji\/15.0.3\/svg\/","svgExt":".svg","source":{"concatemoji":"https:\/\/www.anjusoftware.com\/wp-includes\/js\/wp-emoji-release.min.js?ver=6.6.1"}}; /*! This file is auto-generated */ !function(i,n){var o,s,e;function c(e){try{var t={supportTests:e,timestamp:(new Date).valueOf()};sessionStorage.setItem(o,JSON.stringify(t))}catch(e){}}function p(e,t,n){e.clearRect(0,0,e.canvas.width,e.canvas.height),e.fillText(t,0,0);var t=new Uint32Array(e.getImageData(0,0,e.canvas.width,e.canvas.height).data),r=(e.clearRect(0,0,e.canvas.width,e.canvas.height),e.fillText(n,0,0),new Uint32Array(e.getImageData(0,0,e.canvas.width,e.canvas.height).data));return t.every(function(e,t){return e===r[t]})}function u(e,t,n){switch(t){case"flag":return n(e,"\ud83c\udff3\ufe0f\u200d\u26a7\ufe0f","\ud83c\udff3\ufe0f\u200b\u26a7\ufe0f")?!1:!n(e,"\ud83c\uddfa\ud83c\uddf3","\ud83c\uddfa\u200b\ud83c\uddf3")&&!n(e,"\ud83c\udff4\udb40\udc67\udb40\udc62\udb40\udc65\udb40\udc6e\udb40\udc67\udb40\udc7f","\ud83c\udff4\u200b\udb40\udc67\u200b\udb40\udc62\u200b\udb40\udc65\u200b\udb40\udc6e\u200b\udb40\udc67\u200b\udb40\udc7f");case"emoji":return!n(e,"\ud83d\udc26\u200d\u2b1b","\ud83d\udc26\u200b\u2b1b")}return!1}function f(e,t,n){var r="undefined"!=typeof WorkerGlobalScope&&self instanceof WorkerGlobalScope?new OffscreenCanvas(300,150):i.createElement("canvas"),a=r.getContext("2d",{willReadFrequently:!0}),o=(a.textBaseline="top",a.font="600 32px Arial",{});return e.forEach(function(e){o[e]=t(a,e,n)}),o}function t(e){var t=i.createElement("script");t.src=e,t.defer=!0,i.head.appendChild(t)}"undefined"!=typeof Promise&&(o="wpEmojiSettingsSupports",s=["flag","emoji"],n.supports={everything:!0,everythingExceptFlag:!0},e=new Promise(function(e){i.addEventListener("DOMContentLoaded",e,{once:!0})}),new Promise(function(t){var n=function(){try{var e=JSON.parse(sessionStorage.getItem(o));if("object"==typeof e&&"number"==typeof e.timestamp&&(new Date).valueOf()<e.timestamp+604800&&"object"==typeof e.supportTests)return e.supportTests}catch(e){}return null}();if(!n){if("undefined"!=typeof Worker&&"undefined"!=typeof OffscreenCanvas&&"undefined"!=typeof URL&&URL.createObjectURL&&"undefined"!=typeof Blob)try{var e="postMessage("+f.toString()+"("+[JSON.stringify(s),u.toString(),p.toString()].join(",")+"));",r=new Blob([e],{type:"text/javascript"}),a=new Worker(URL.createObjectURL(r),{name:"wpTestEmojiSupports"});return void(a.onmessage=function(e){c(n=e.data),a.terminate(),t(n)})}catch(e){}c(n=f(s,u,p))}t(n)}).then(function(e){for(var t in e)n.supports[t]=e[t],n.supports.everything=n.supports.everything&&n.supports[t],"flag"!==t&&(n.supports.everythingExceptFlag=n.supports.everythingExceptFlag&&n.supports[t]);n.supports.everythingExceptFlag=n.supports.everythingExceptFlag&&!n.supports.flag,n.DOMReady=!1,n.readyCallback=function(){n.DOMReady=!0}}).then(function(){return e}).then(function(){var e;n.supports.everything||(n.readyCallback(),(e=n.source||{}).concatemoji?t(e.concatemoji):e.wpemoji&&e.twemoji&&(t(e.twemoji),t(e.wpemoji)))}))}((window,document),window._wpemojiSettings); /* ]]> */ </script> <style id='wp-emoji-styles-inline-css' type='text/css'> img.wp-smiley, img.emoji { display: inline !important; border: none !important; box-shadow: none !important; height: 1em !important; width: 1em !important; margin: 0 0.07em !important; vertical-align: -0.1em !important; background: none !important; padding: 0 !important; } </style> <style id='wp-block-library-inline-css' type='text/css'> :root{--wp-admin-theme-color:#007cba;--wp-admin-theme-color--rgb:0,124,186;--wp-admin-theme-color-darker-10:#006ba1;--wp-admin-theme-color-darker-10--rgb:0,107,161;--wp-admin-theme-color-darker-20:#005a87;--wp-admin-theme-color-darker-20--rgb:0,90,135;--wp-admin-border-width-focus:2px;--wp-block-synced-color:#7a00df;--wp-block-synced-color--rgb:122,0,223;--wp-bound-block-color:var(--wp-block-synced-color)}@media (min-resolution:192dpi){:root{--wp-admin-border-width-focus:1.5px}}.wp-element-button{cursor:pointer}:root{--wp--preset--font-size--normal:16px;--wp--preset--font-size--huge:42px}:root .has-very-light-gray-background-color{background-color:#eee}:root .has-very-dark-gray-background-color{background-color:#313131}:root .has-very-light-gray-color{color:#eee}:root .has-very-dark-gray-color{color:#313131}:root .has-vivid-green-cyan-to-vivid-cyan-blue-gradient-background{background:linear-gradient(135deg,#00d084,#0693e3)}:root .has-purple-crush-gradient-background{background:linear-gradient(135deg,#34e2e4,#4721fb 50%,#ab1dfe)}:root .has-hazy-dawn-gradient-background{background:linear-gradient(135deg,#faaca8,#dad0ec)}:root .has-subdued-olive-gradient-background{background:linear-gradient(135deg,#fafae1,#67a671)}:root .has-atomic-cream-gradient-background{background:linear-gradient(135deg,#fdd79a,#004a59)}:root .has-nightshade-gradient-background{background:linear-gradient(135deg,#330968,#31cdcf)}:root .has-midnight-gradient-background{background:linear-gradient(135deg,#020381,#2874fc)}.has-regular-font-size{font-size:1em}.has-larger-font-size{font-size:2.625em}.has-normal-font-size{font-size:var(--wp--preset--font-size--normal)}.has-huge-font-size{font-size:var(--wp--preset--font-size--huge)}.has-text-align-center{text-align:center}.has-text-align-left{text-align:left}.has-text-align-right{text-align:right}#end-resizable-editor-section{display:none}.aligncenter{clear:both}.items-justified-left{justify-content:flex-start}.items-justified-center{justify-content:center}.items-justified-right{justify-content:flex-end}.items-justified-space-between{justify-content:space-between}.screen-reader-text{border:0;clip:rect(1px,1px,1px,1px);clip-path:inset(50%);height:1px;margin:-1px;overflow:hidden;padding:0;position:absolute;width:1px;word-wrap:normal!important}.screen-reader-text:focus{background-color:#ddd;clip:auto!important;clip-path:none;color:#444;display:block;font-size:1em;height:auto;left:5px;line-height:normal;padding:15px 23px 14px;text-decoration:none;top:5px;width:auto;z-index:100000}html :where(.has-border-color){border-style:solid}html :where([style*=border-top-color]){border-top-style:solid}html :where([style*=border-right-color]){border-right-style:solid}html :where([style*=border-bottom-color]){border-bottom-style:solid}html :where([style*=border-left-color]){border-left-style:solid}html :where([style*=border-width]){border-style:solid}html :where([style*=border-top-width]){border-top-style:solid}html :where([style*=border-right-width]){border-right-style:solid}html :where([style*=border-bottom-width]){border-bottom-style:solid}html :where([style*=border-left-width]){border-left-style:solid}html :where(img[class*=wp-image-]){height:auto;max-width:100%}:where(figure){margin:0 0 1em}html :where(.is-position-sticky){--wp-admin--admin-bar--position-offset:var(--wp-admin--admin-bar--height,0px)}@media screen and (max-width:600px){html :where(.is-position-sticky){--wp-admin--admin-bar--position-offset:0px}} </style> <style id='classic-theme-styles-inline-css' type='text/css'> /*! This file is auto-generated */ .wp-block-button__link{color:#fff;background-color:#32373c;border-radius:9999px;box-shadow:none;text-decoration:none;padding:calc(.667em + 2px) calc(1.333em + 2px);font-size:1.125em}.wp-block-file__button{background:#32373c;color:#fff;text-decoration:none} </style> <link rel='stylesheet' id='contact-form-7-css' href='https://www.anjusoftware.com/wp-content/plugins/contact-form-7/includes/css/styles.css?ver=6.0' type='text/css' media='all' /> <link rel='stylesheet' id='parent-style-css' href='https://www.anjusoftware.com/wp-content/themes/bootscore-main/style.css?ver=6.6.1' type='text/css' media='all' /> <link rel='stylesheet' id='mcs_bootstrap_style-css' href='https://www.anjusoftware.com/wp-content/themes/bootscore-child-main/assets/css/bootstrap5.css?ver=6.6.1' type='text/css' media='all' /> <link rel='stylesheet' id='mcs_font_family_style-css' href='https://www.anjusoftware.com/wp-content/themes/bootscore-child-main/assets/css/font-family.css?ver=6.6.1' type='text/css' media='all' /> <link rel='stylesheet' id='mcs_local_owl_css-css' href='https://www.anjusoftware.com/wp-content/themes/bootscore-child-main/assets/css/owl.min.css?ver=6.6.1' type='text/css' media='all' /> <link rel='stylesheet' id='mcs_local_owldefault_css-css' href='https://www.anjusoftware.com/wp-content/themes/bootscore-child-main/assets/css/owl_default.css?ver=6.6.1' type='text/css' media='all' /> <link rel='stylesheet' id='mcs_sub_style-css' href='https://www.anjusoftware.com/wp-content/themes/bootscore-child-main/assets/css/second.css?ver=6.6.1' type='text/css' media='all' /> <link rel='stylesheet' id='mcs_main_style-css' href='https://www.anjusoftware.com/wp-content/themes/bootscore-child-main/assets/css/main.css?ver=6.6.1' type='text/css' media='all' /> <link rel='stylesheet' id='p2_styles-css' href='https://www.anjusoftware.com/wp-content/themes/bootscore-child-main/assets/css/p2.css?ver=1.000002' type='text/css' media='all' /> <link rel='stylesheet' id='main-css' href='https://www.anjusoftware.com/wp-content/themes/bootscore-main/css/main.css?ver=202301272028' type='text/css' media='all' /> <link rel='stylesheet' id='bootscore-style-css' href='https://www.anjusoftware.com/wp-content/themes/bootscore-child-main/style.css?ver=202404241413' type='text/css' media='all' /> <link rel='stylesheet' id='fontawesome-css' online="if(media!='all')media='all'" href='https://www.anjusoftware.com/wp-content/themes/bootscore-main/fontawesome/css/all.min.css?ver=202301272028' type='text/css' media='all' /> <link rel='stylesheet' id='heateor_sss_frontend_css-css' href='https://www.anjusoftware.com/wp-content/plugins/sassy-social-share/public/css/sassy-social-share-public.css?ver=3.3.70' type='text/css' media='all' /> <style id='heateor_sss_frontend_css-inline-css' type='text/css'> .heateor_sss_button_instagram span.heateor_sss_svg,a.heateor_sss_instagram span.heateor_sss_svg{background:radial-gradient(circle at 30% 107%,#fdf497 0,#fdf497 5%,#fd5949 45%,#d6249f 60%,#285aeb 90%)}div.heateor_sss_horizontal_sharing a.heateor_sss_button_instagram span{background:transparent!important;}div.heateor_sss_standard_follow_icons_container a.heateor_sss_button_instagram span{background:transparent}.heateor_sss_horizontal_sharing .heateor_sss_svg,.heateor_sss_standard_follow_icons_container .heateor_sss_svg{background-color:transparent!important;background:transparent!important;color:#00caf9;border-width:0px;border-style:solid;border-color:transparent}.heateor_sss_horizontal_sharing span.heateor_sss_svg:hover,.heateor_sss_standard_follow_icons_container span.heateor_sss_svg:hover{border-color:transparent;}.heateor_sss_vertical_sharing span.heateor_sss_svg,.heateor_sss_floating_follow_icons_container span.heateor_sss_svg{color:#fff;border-width:0px;border-style:solid;border-color:transparent;}.heateor_sss_vertical_sharing span.heateor_sss_svg:hover,.heateor_sss_floating_follow_icons_container span.heateor_sss_svg:hover{border-color:transparent;}@media screen and (max-width:783px) {.heateor_sss_vertical_sharing{display:none!important}} </style> <script type="text/javascript" src="//ajax.googleapis.com/ajax/libs/jquery/3.6.1/jquery.min.js?ver=6.6.1" id="mcs_local_jquery-js"></script> <script type="text/javascript" src="https://www.anjusoftware.com/wp-includes/js/jquery/jquery.min.js?ver=3.7.1" id="jquery-core-js"></script> <script type="text/javascript" src="https://www.anjusoftware.com/wp-includes/js/jquery/jquery-migrate.min.js?ver=3.4.1" id="jquery-migrate-js"></script> <!-- Google tag (gtag.js) snippet added by Site Kit --> <!-- Google Analytics snippet added by Site Kit --> <script type="text/javascript" src="https://www.googletagmanager.com/gtag/js?id=G-BTL2N9CW9G" id="google_gtagjs-js" async></script> <script type="text/javascript" id="google_gtagjs-js-after"> /* <![CDATA[ */ window.dataLayer = window.dataLayer || [];function gtag(){dataLayer.push(arguments);} gtag("set","linker",{"domains":["www.anjusoftware.com"]}); gtag("js", new Date()); gtag("set", "developer_id.dZTNiMT", true); gtag("config", "G-BTL2N9CW9G"); window._googlesitekit = window._googlesitekit || {}; window._googlesitekit.throttledEvents = []; window._googlesitekit.gtagEvent = (name, data) => { var key = JSON.stringify( { name, data } ); if ( !! window._googlesitekit.throttledEvents[ key ] ) { return; } window._googlesitekit.throttledEvents[ key ] = true; setTimeout( () => { delete window._googlesitekit.throttledEvents[ key ]; }, 5 ); gtag( "event", name, { ...data, event_source: "site-kit" } ); } /* ]]> */ </script> <!-- End Google tag (gtag.js) snippet added by Site Kit --> <link rel="https://api.w.org/" href="https://www.anjusoftware.com/wp-json/" /><link rel="alternate" title="JSON" type="application/json" href="https://www.anjusoftware.com/wp-json/wp/v2/posts/1561" /><link rel="EditURI" type="application/rsd+xml" title="RSD" href="https://www.anjusoftware.com/xmlrpc.php?rsd" /> <link rel='shortlink' href='https://www.anjusoftware.com/?p=1561' /> <link rel="alternate" title="oEmbed (JSON)" type="application/json+oembed" href="https://www.anjusoftware.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fwww.anjusoftware.com%2Finsights%2Feclinical%2Fpatient-engagement%2Frare-disease-trial-outcomes%2F" /> <link rel="alternate" title="oEmbed (XML)" type="text/xml+oembed" href="https://www.anjusoftware.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fwww.anjusoftware.com%2Finsights%2Feclinical%2Fpatient-engagement%2Frare-disease-trial-outcomes%2F&format=xml" /> <meta name="generator" content="Site Kit by Google 1.140.0" /><link rel="pingback" href="https://www.anjusoftware.com/xmlrpc.php"><meta name="generator" content="Elementor 3.25.10; features: additional_custom_breakpoints, e_optimized_control_loading; settings: css_print_method-external, google_font-enabled, font_display-swap"> <style> .e-con.e-parent:nth-of-type(n+4):not(.e-lazyloaded):not(.e-no-lazyload), .e-con.e-parent:nth-of-type(n+4):not(.e-lazyloaded):not(.e-no-lazyload) * { background-image: none !important; } @media screen and (max-height: 1024px) { .e-con.e-parent:nth-of-type(n+3):not(.e-lazyloaded):not(.e-no-lazyload), .e-con.e-parent:nth-of-type(n+3):not(.e-lazyloaded):not(.e-no-lazyload) * { background-image: none !important; } } @media screen and (max-height: 640px) { .e-con.e-parent:nth-of-type(n+2):not(.e-lazyloaded):not(.e-no-lazyload), .e-con.e-parent:nth-of-type(n+2):not(.e-lazyloaded):not(.e-no-lazyload) * { background-image: none !important; } } </style> <link rel="icon" href="https://www.anjusoftware.com/wp-content/uploads/2024/04/anju-favicon-150x150.png" sizes="32x32" /> <link rel="icon" href="https://www.anjusoftware.com/wp-content/uploads/2024/04/anju-favicon-300x300.png" sizes="192x192" /> <link rel="apple-touch-icon" href="https://www.anjusoftware.com/wp-content/uploads/2024/04/anju-favicon-300x300.png" /> <meta name="msapplication-TileImage" content="https://www.anjusoftware.com/wp-content/uploads/2024/04/anju-favicon-300x300.png" /> <style type="text/css" id="wp-custom-css"> @media(min-width: 200px) { .careers-banner ul { font-size: 1.5rem; line-height: 2.4rem; font-weight: 400; } } @media(min-width: 767px) { .careers-banner ul { font-size: 1.8rem; line-height: 2.8rem; } .management_leaders img { height: 300px; object-fit: cover; } } @media(min-width: 1024px) { .careers-banner ul { font-size: 1.5rem; line-height: 2.4rem; } } .single-post #content p{font-weight:400} .single-post #content ul li { color: var(--text-gray-700); } @media(min-width:600px){ .single-post p>img:not(.bootscore-footer img) { width: auto; float: left; margin-right: 25px; } } </style> </head> <body class="post-template-default single single-post postid-1561 single-format-standard no-sidebar elementor-default elementor-kit-3189"> <!-- Google Tag Manager (noscript) --> <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-WWQHZDD7" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <!-- End Google Tag Manager (noscript) --> <!-- custom header --> <div id="main-wrapper"> <!-- begin header --> <header class="header"> <nav class="navbar navbar-expand-xl"> <div class="container"> <a class="navbar-brand" href="https://www.anjusoftware.com/"><img class="img-fluid" src="https://www.anjusoftware.com/wp-content/uploads/2023/01/anju-software-log.svg" alt="Anju Software"></a> <button class="navbar-toggler" type="button" data-bs-toggle="offcanvas" data-bs-target="#offcanvasNavbar" aria-controls="offcanvasNavbar"> <span class="navbar-toggler-icon"></span> </button> <div class="offcanvas offcanvas-end" tabindex="-1" id="offcanvasNavbar" aria-labelledby="offcanvasNavbarLabel" data-autohide="false"> <div class="offcanvas-header"> <button type="button" class="btn-close" data-bs-dismiss="offcanvas" aria-label="Close"></button> </div> <div class="offcanvas-body" data-autohide="false"> <ul id="menu-primary-menu" class="navbar-nav me-auto mb-2 mb-md-0 "><li id="menu-item-2151" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-has-children dropdown nav-item nav-item-2151 def0"><a href="#" class="nav-link dropdown-toggle" data-bs-toggle="dropdown" aria-haspopup="true" aria-expanded="false">Solutions</a> <ul class="dropdown-menu depth_0"> <li id="menu-item-131" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children dropdown nav-item nav-item-131 def1 dropdown-menu dropdown-menu-end"><a href="https://www.anjusoftware.com/eclinical/" class="dropdown-item dropdown-toggle" data-bs-toggle="dropdown" aria-haspopup="true" aria-expanded="false">eClinical</a> <ul class="dropdown-menusub-menu depth_1"> <li id="menu-item-263" class="menu-item menu-item-type-post_type menu-item-object-page nav-item nav-item-263 def2"><a href="https://www.anjusoftware.com/trial-master/" class="dropdown-item ">TrialMaster</a></li> <li id="menu-item-231" class="menu-item menu-item-type-post_type menu-item-object-page nav-item nav-item-231 def2"><a href="https://www.anjusoftware.com/eclinical/ctms-master/" class="dropdown-item ">CTMS Master</a></li> <li id="menu-item-4675" class="menu-item menu-item-type-post_type menu-item-object-page nav-item nav-item-4675 def2"><a href="https://www.anjusoftware.com/eclinical/rtsm-master/" class="dropdown-item ">RTSM Master</a></li> <li id="menu-item-4676" class="menu-item menu-item-type-post_type menu-item-object-page nav-item nav-item-4676 def2"><a href="https://www.anjusoftware.com/eclinical/anjueps/" class="dropdown-item ">AnjuEPS</a></li> </ul> </li> <li id="menu-item-130" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children dropdown nav-item nav-item-130 def1 dropdown-menu dropdown-menu-end"><a href="https://www.anjusoftware.com/medical-affairs/" class="dropdown-item dropdown-toggle" data-bs-toggle="dropdown" aria-haspopup="true" aria-expanded="false">Medical Affairs</a> <ul class="dropdown-menusub-menu depth_1"> <li id="menu-item-246" class="menu-item menu-item-type-post_type menu-item-object-page nav-item nav-item-246 def2"><a href="https://www.anjusoftware.com/medical-affairs/irms-max/" class="dropdown-item ">IRMS MAX</a></li> <li id="menu-item-245" class="menu-item menu-item-type-post_type menu-item-object-page nav-item nav-item-245 def2"><a href="https://www.anjusoftware.com/medical-affairs/icare-max/" class="dropdown-item ">iCare MAX</a></li> <li id="menu-item-247" class="menu-item menu-item-type-post_type menu-item-object-page nav-item nav-item-247 def2"><a href="https://www.anjusoftware.com/medical-affairs/pubstrat-max/" class="dropdown-item ">Pubstrat MAX</a></li> <li id="menu-item-4496" class="menu-item menu-item-type-post_type menu-item-object-page nav-item nav-item-4496 def2"><a href="https://www.anjusoftware.com/medical-affairs/ma-knowledge/" class="dropdown-item ">MA Knowledge</a></li> </ul> </li> <li id="menu-item-129" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children dropdown nav-item nav-item-129 def1 dropdown-menu dropdown-menu-end"><a href="https://www.anjusoftware.com/data-science/" class="dropdown-item dropdown-toggle" data-bs-toggle="dropdown" aria-haspopup="true" aria-expanded="false">Data Science</a> <ul class="dropdown-menusub-menu depth_1"> <li id="menu-item-2237" class="menu-item menu-item-type-post_type menu-item-object-page nav-item nav-item-2237 def2"><a href="https://www.anjusoftware.com/ta-scan-data-science/" class="dropdown-item ">TA Scan</a></li> </ul> </li> </ul> </li> <li id="menu-item-2152" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-has-children dropdown nav-item nav-item-2152 def0"><a href="#" class="nav-link dropdown-toggle" data-bs-toggle="dropdown" aria-haspopup="true" aria-expanded="false">Services</a> <ul class="dropdown-menu depth_0"> <li id="menu-item-2052" class="menu-item menu-item-type-post_type menu-item-object-page nav-item nav-item-2052 def1"><a href="https://www.anjusoftware.com/eclinical-services/" class="dropdown-item ">eClinical Services</a></li> <li id="menu-item-2053" class="menu-item menu-item-type-post_type menu-item-object-page nav-item nav-item-2053 def1"><a href="https://www.anjusoftware.com/medical-affairs-services/" class="dropdown-item ">Medical Affairs Services</a></li> <li id="menu-item-2454" class="menu-item menu-item-type-post_type menu-item-object-page nav-item nav-item-2454 def1"><a href="https://www.anjusoftware.com/data-science-services/" class="dropdown-item ">Data Science Services</a></li> </ul> </li> <li id="menu-item-48" class="menu-item menu-item-type-post_type menu-item-object-page nav-item nav-item-48 def0"><a href="https://www.anjusoftware.com/technology/" class="nav-link ">Technology</a></li> <li id="menu-item-2153" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-has-children dropdown nav-item nav-item-2153 def0"><a href="#" class="nav-link dropdown-toggle" data-bs-toggle="dropdown" aria-haspopup="true" aria-expanded="false">Resources</a> <ul class="dropdown-menu depth_0"> <li id="menu-item-2054" class="menu-item menu-item-type-post_type menu-item-object-page nav-item nav-item-2054 def1"><a href="https://www.anjusoftware.com/insights/" class="dropdown-item ">Insights</a></li> <li id="menu-item-2055" class="menu-item menu-item-type-post_type menu-item-object-page nav-item nav-item-2055 def1"><a href="https://www.anjusoftware.com/press-releases/" class="dropdown-item ">Press Releases</a></li> <li id="menu-item-2056" class="menu-item menu-item-type-post_type menu-item-object-page nav-item nav-item-2056 def1"><a href="https://www.anjusoftware.com/events/" class="dropdown-item ">Events</a></li> </ul> </li> <li id="menu-item-2060" class="menu-item menu-item-type-post_type menu-item-object-page nav-item nav-item-2060 def0"><a href="https://www.anjusoftware.com/partner-program/" class="nav-link ">Partner Program</a></li> <li id="menu-item-2154" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-has-children dropdown nav-item nav-item-2154 def0"><a href="#" class="nav-link dropdown-toggle" data-bs-toggle="dropdown" aria-haspopup="true" aria-expanded="false">Company</a> <ul class="dropdown-menu depth_0"> <li id="menu-item-2057" class="menu-item menu-item-type-post_type menu-item-object-page nav-item nav-item-2057 def1"><a href="https://www.anjusoftware.com/about-anju/" class="dropdown-item ">About Anju</a></li> <li id="menu-item-2058" class="menu-item menu-item-type-post_type menu-item-object-page nav-item nav-item-2058 def1"><a href="https://www.anjusoftware.com/careers/" class="dropdown-item ">Careers</a></li> <li id="menu-item-2059" class="menu-item menu-item-type-post_type menu-item-object-page nav-item nav-item-2059 def1"><a href="https://www.anjusoftware.com/ingishts/management/" class="dropdown-item ">Management</a></li> </ul> </li> <li id="menu-item-2061" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-has-children dropdown nav-item nav-item-2061 def0"><a href="#" class="nav-link dropdown-toggle" data-bs-toggle="dropdown" aria-haspopup="true" aria-expanded="false">Contact Us</a> <ul class="dropdown-menu depth_0"> <li id="menu-item-2062" class="menu-item menu-item-type-post_type menu-item-object-page nav-item nav-item-2062 def1"><a href="https://www.anjusoftware.com/customer-support/" class="dropdown-item ">Contact Support</a></li> <li id="menu-item-2063" class="menu-item menu-item-type-post_type menu-item-object-page nav-item nav-item-2063 def1"><a href="https://www.anjusoftware.com/request-a-demo/" class="dropdown-item ">Request A Demo</a></li> <li id="menu-item-2064" class="menu-item menu-item-type-post_type menu-item-object-page nav-item nav-item-2064 def1"><a href="https://www.anjusoftware.com/inquiries-locations/" class="dropdown-item ">Inquiries & Locations</a></li> </ul> </li> </ul> <!-- <button class="btn btn-blue-900 header-contact-us">Contact Us</button> --> <!-- <a href="/enquiries-and-locations/"> <button class="btn btn-blue-900 header-contact-us">Contact Us</button></a> --> </div> </div> </div> </nav> </header> <div id="page" class="site"> <script type="application/ld+json"> { "@context": "https://schema.org", "@type": "Article", "headline": "Rare Disease Clinical Trials: How to Improve Participation and Outcomes", "image": [ "https://www.anjusoftware.com/wp-content/uploads/2023/01/rare-disease-clinical-trials-how-to-improve-participation-and-outcomes.webp" ], "datePublished": "January 29, 2019", "dateModified": "March 25, 2024", "author": [{ "@type": "Person", "name": "Lisa Pahl" }] } </script> <div class="breadcrumbs container purple"> <div class="columns"> <div class="column"> <p id="breadcrumbs"><span><span><a href="https://www.anjusoftware.com/">Home</a></span> / <span><a href="https://www.anjusoftware.com/insights/">Insights</a></span> / <span class="breadcrumb_last" aria-current="page">Rare Disease Clinical Trials: How to Improve Participation and Outcomes</span></span></p> </div> </div> </div> <div id="content" class="site-content container py-5 mt-4"> <div id="primary" class="content-area"> <!-- Hook to add something nice --> <nav aria-label="breadcrumb" class="breadcrumb-scroller mb-4 mt-2 py-2 px-3 bg-light rounded"><ol class="breadcrumb mb-0"><li class="breadcrumb-item"><a href="https://www.anjusoftware.com"><i class="fa-solid fa-house"></i></a></li><li class="breadcrumb-item"><a href="https://www.anjusoftware.com/category/insights/eclinical/">eClinical</a></li><li class="breadcrumb-item"><a href="https://www.anjusoftware.com/category/insights/">Insights</a></li><li class="breadcrumb-item"><a href="https://www.anjusoftware.com/category/insights/eclinical/patient-engagement/">Patient Engagement</a></li><li class="breadcrumb-item active" aria-current="page">Rare Disease Clinical Trials: How to Improve Participation and Outcomes</li></ol></nav></nav> <main id="main" class="site-main"> <div class="row"> <button class="btn toggle-blog-sidebar"><i class="fa-solid fa-filter"></i> Filter Blogs</button> <div class="col-md-3 sidebar-tags"> <button class="close-blog-sidebar btn-blue-700"><i class="fa-solid fa-xmark"></i></button> <div class="main-category"> <a href="https://www.anjusoftware.com/category/insights/data-science/">Data Science</a> <ul class="sub-categories"> <li><a href="https://www.anjusoftware.com/category/insights/data-science/clinical-trial-design/">Clinical Trial Design</a></li> <li><a href="https://www.anjusoftware.com/category/insights/data-science/feasibility/">Feasibility</a></li> <li><a href="https://www.anjusoftware.com/category/insights/data-science/site-identification/">Site Identification</a></li> <li><a href="https://www.anjusoftware.com/category/insights/data-science/ta-scan/">TA Scan</a></li> </ul> </div> <div class="main-category"> <a href="https://www.anjusoftware.com/category/insights/eclinical/">eClinical</a> <ul class="sub-categories"> <li><a href="https://www.anjusoftware.com/category/insights/eclinical/ctms/">CTMS</a></li> <li><a href="https://www.anjusoftware.com/category/insights/eclinical/data-privacy/">Data Privacy</a></li> <li><a href="https://www.anjusoftware.com/category/insights/eclinical/decentralized-trials/">Decentralized Trials</a></li> <li><a href="https://www.anjusoftware.com/category/insights/eclinical/ecoa/">eCOA</a></li> <li><a href="https://www.anjusoftware.com/category/insights/eclinical/econsent-eclinical/">eConsent</a></li> <li><a href="https://www.anjusoftware.com/category/insights/eclinical/edc/">EDC</a></li> <li><a href="https://www.anjusoftware.com/category/insights/eclinical/epro/">ePRO</a></li> <li><a href="https://www.anjusoftware.com/category/insights/eclinical/etmf/">eTMF</a></li> <li><a href="https://www.anjusoftware.com/category/insights/eclinical/patient-engagement/">Patient Engagement</a></li> <li><a href="https://www.anjusoftware.com/category/insights/eclinical/rtsm/">RTSM</a></li> </ul> </div> <div class="main-category"> <a href="https://www.anjusoftware.com/category/insights/medical-affairs/">Medical Affairs</a> <ul class="sub-categories"> <li><a href="https://www.anjusoftware.com/category/insights/medical-affairs/kol/">KOL</a></li> <li><a href="https://www.anjusoftware.com/category/insights/medical-affairs/medical-information/">Medical Information</a></li> <li><a href="https://www.anjusoftware.com/category/insights/medical-affairs/msl/">MSL</a></li> <li><a href="https://www.anjusoftware.com/category/insights/medical-affairs/patient-engagement-medical-affairs/">Patient Engagement</a></li> <li><a href="https://www.anjusoftware.com/category/insights/medical-affairs/publication-planning-medical-affairs/">Publication Planning</a></li> </ul> </div> <div class="singlePost-mainPage-links"> <a href="https://anjudev.wpengine.com/insights/">Insights</a> <a href="https://anjudev.wpengine.com/press-releases/">Press Release</a> <a href="https://anjudev.wpengine.com/events/">Events</a> </div> </div> <div class="col-md-9"> <header class="entry-header"> <div class="category-badge mb-2"><a href="https://www.anjusoftware.com/category/insights/eclinical/" class="badge text-bg-secondary text-decoration-none">eClinical</a> <a href="https://www.anjusoftware.com/category/insights/" class="badge text-bg-secondary text-decoration-none">Insights</a> <a href="https://www.anjusoftware.com/category/insights/eclinical/patient-engagement/" class="badge text-bg-secondary text-decoration-none">Patient Engagement</a></div> <div class="post-thumbnail"> <img fetchpriority="high" width="1030" height="687" src="https://www.anjusoftware.com/wp-content/uploads/2023/01/rare-disease-clinical-trials-how-to-improve-participation-and-outcomes.webp" class="rounded mb-3 wp-post-image" alt="Rare Disease Clinical Trials" decoding="async" srcset="https://www.anjusoftware.com/wp-content/uploads/2023/01/rare-disease-clinical-trials-how-to-improve-participation-and-outcomes.webp 1030w, https://www.anjusoftware.com/wp-content/uploads/2023/01/rare-disease-clinical-trials-how-to-improve-participation-and-outcomes-300x200.webp 300w, https://www.anjusoftware.com/wp-content/uploads/2023/01/rare-disease-clinical-trials-how-to-improve-participation-and-outcomes-1024x683.webp 1024w, https://www.anjusoftware.com/wp-content/uploads/2023/01/rare-disease-clinical-trials-how-to-improve-participation-and-outcomes-768x512.webp 768w" sizes="(max-width: 1030px) 100vw, 1030px" /> </div><!-- .post-thumbnail --> <h1>Rare Disease Clinical Trials: How to Improve Participation and Outcomes</h1> <div class="meta_data"> <p class="entry-meta"> <small class="text-muted"> <!--   --> January 29, 2019 </small> </p> <div class="heateor_sss_sharing_container heateor_sss_horizontal_sharing" data-heateor-ss-offset="0" data-heateor-sss-href='https://www.anjusoftware.com/insights/eclinical/patient-engagement/rare-disease-trial-outcomes/'><div class="heateor_sss_sharing_ul"><a aria-label="Facebook" class="heateor_sss_facebook" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.anjusoftware.com%2Finsights%2Feclinical%2Fpatient-engagement%2Frare-disease-trial-outcomes%2F" title="Facebook" rel="nofollow noopener" target="_blank" style="font-size:32px!important;box-shadow:none;display:inline-block;vertical-align:middle"><span class="heateor_sss_svg" style="background-color:#0765FE;width:25px;height:25px;border-radius:999px;display:inline-block;opacity:1;float:left;font-size:32px;box-shadow:none;display:inline-block;font-size:16px;padding:0 4px;vertical-align:middle;background-repeat:repeat;overflow:hidden;padding:0;cursor:pointer;box-sizing:content-box"><svg style="display:block;border-radius:999px;" focusable="false" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" width="100%" height="100%" viewBox="0 0 32 32"><path fill="#00caf9" d="M28 16c0-6.627-5.373-12-12-12S4 9.373 4 16c0 5.628 3.875 10.35 9.101 11.647v-7.98h-2.474V16H13.1v-1.58c0-4.085 1.849-5.978 5.859-5.978.76 0 2.072.15 2.608.298v3.325c-.283-.03-.775-.045-1.386-.045-1.967 0-2.728.745-2.728 2.683V16h3.92l-.673 3.667h-3.247v8.245C23.395 27.195 28 22.135 28 16Z"></path></svg></span></a><a aria-label="Twitter" class="heateor_sss_button_twitter" href="http://twitter.com/intent/tweet?text=Rare%20Disease%20Clinical%20Trials%3A%20How%20to%20Improve%20Participation%20and%20Outcomes&url=https%3A%2F%2Fwww.anjusoftware.com%2Finsights%2Feclinical%2Fpatient-engagement%2Frare-disease-trial-outcomes%2F" title="Twitter" rel="nofollow noopener" target="_blank" style="font-size:32px!important;box-shadow:none;display:inline-block;vertical-align:middle"><span class="heateor_sss_svg heateor_sss_s__default heateor_sss_s_twitter" style="background-color:#55acee;width:25px;height:25px;border-radius:999px;display:inline-block;opacity:1;float:left;font-size:32px;box-shadow:none;display:inline-block;font-size:16px;padding:0 4px;vertical-align:middle;background-repeat:repeat;overflow:hidden;padding:0;cursor:pointer;box-sizing:content-box"><svg style="display:block;border-radius:999px;" focusable="false" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" width="100%" height="100%" viewBox="-4 -4 39 39"><path d="M28 8.557a9.913 9.913 0 0 1-2.828.775 4.93 4.93 0 0 0 2.166-2.725 9.738 9.738 0 0 1-3.13 1.194 4.92 4.92 0 0 0-3.593-1.55 4.924 4.924 0 0 0-4.794 6.049c-4.09-.21-7.72-2.17-10.15-5.15a4.942 4.942 0 0 0-.665 2.477c0 1.71.87 3.214 2.19 4.1a4.968 4.968 0 0 1-2.23-.616v.06c0 2.39 1.7 4.38 3.952 4.83-.414.115-.85.174-1.297.174-.318 0-.626-.03-.928-.086a4.935 4.935 0 0 0 4.6 3.42 9.893 9.893 0 0 1-6.114 2.107c-.398 0-.79-.023-1.175-.068a13.953 13.953 0 0 0 7.55 2.213c9.056 0 14.01-7.507 14.01-14.013 0-.213-.005-.426-.015-.637.96-.695 1.795-1.56 2.455-2.55z" fill="#00caf9"></path></svg></span></a><a aria-label="Linkedin" class="heateor_sss_button_linkedin" href="https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.anjusoftware.com%2Finsights%2Feclinical%2Fpatient-engagement%2Frare-disease-trial-outcomes%2F" title="Linkedin" rel="nofollow noopener" target="_blank" style="font-size:32px!important;box-shadow:none;display:inline-block;vertical-align:middle"><span class="heateor_sss_svg heateor_sss_s__default heateor_sss_s_linkedin" style="background-color:#0077b5;width:25px;height:25px;border-radius:999px;display:inline-block;opacity:1;float:left;font-size:32px;box-shadow:none;display:inline-block;font-size:16px;padding:0 4px;vertical-align:middle;background-repeat:repeat;overflow:hidden;padding:0;cursor:pointer;box-sizing:content-box"><svg style="display:block;border-radius:999px;" focusable="false" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" width="100%" height="100%" viewBox="0 0 32 32"><path d="M6.227 12.61h4.19v13.48h-4.19V12.61zm2.095-6.7a2.43 2.43 0 0 1 0 4.86c-1.344 0-2.428-1.09-2.428-2.43s1.084-2.43 2.428-2.43m4.72 6.7h4.02v1.84h.058c.56-1.058 1.927-2.176 3.965-2.176 4.238 0 5.02 2.792 5.02 6.42v7.395h-4.183v-6.56c0-1.564-.03-3.574-2.178-3.574-2.18 0-2.514 1.7-2.514 3.46v6.668h-4.187V12.61z" fill="#00caf9"></path></svg></span></a><a aria-label="Pinterest" class="heateor_sss_button_pinterest" href="https://www.anjusoftware.com/insights/eclinical/patient-engagement/rare-disease-trial-outcomes/" onclick="event.preventDefault();javascript:void( (function() {var e=document.createElement('script' );e.setAttribute('type','text/javascript' );e.setAttribute('charset','UTF-8' );e.setAttribute('src','//assets.pinterest.com/js/pinmarklet.js?r='+Math.random()*99999999);document.body.appendChild(e)})());" title="Pinterest" rel="noopener" style="font-size:32px!important;box-shadow:none;display:inline-block;vertical-align:middle"><span class="heateor_sss_svg heateor_sss_s__default heateor_sss_s_pinterest" style="background-color:#cc2329;width:25px;height:25px;border-radius:999px;display:inline-block;opacity:1;float:left;font-size:32px;box-shadow:none;display:inline-block;font-size:16px;padding:0 4px;vertical-align:middle;background-repeat:repeat;overflow:hidden;padding:0;cursor:pointer;box-sizing:content-box"><svg style="display:block;border-radius:999px;" focusable="false" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" width="100%" height="100%" viewBox="-2 -2 35 35"><path fill="#00caf9" d="M16.539 4.5c-6.277 0-9.442 4.5-9.442 8.253 0 2.272.86 4.293 2.705 5.046.303.125.574.005.662-.33.061-.231.205-.816.27-1.06.088-.331.053-.447-.191-.736-.532-.627-.873-1.439-.873-2.591 0-3.338 2.498-6.327 6.505-6.327 3.548 0 5.497 2.168 5.497 5.062 0 3.81-1.686 7.025-4.188 7.025-1.382 0-2.416-1.142-2.085-2.545.397-1.674 1.166-3.48 1.166-4.689 0-1.081-.581-1.983-1.782-1.983-1.413 0-2.548 1.462-2.548 3.419 0 1.247.421 2.091.421 2.091l-1.699 7.199c-.505 2.137-.076 4.755-.039 5.019.021.158.223.196.314.077.13-.17 1.813-2.247 2.384-4.324.162-.587.929-3.631.929-3.631.46.876 1.801 1.646 3.227 1.646 4.247 0 7.128-3.871 7.128-9.053.003-3.918-3.317-7.568-8.361-7.568z"/></svg></span></a></div><div class="heateorSssClear"></div></div> </div> </header> <div class="entry-content"> <p>Rare diseases affect around 400 million people around the world, according to the World Health Organization, which defines rare diseases as having a prevalence of one or fewer in 1,000 people. In the US, that’s around 25 to 30 million; in Europe it’s approximately 27 to 36 million, and in India, the estimate is 70 million.</p> <p>Despite rare diseases collectively accounting for a large number of people globally, individual diseases affect remarkably few patients and these are often dispersed all around the world, making these populations difficult to study.</p> <p>This post will explore some of the challenges that patients with rare diseases face as well as how difficult it is to recruit and retain patients in rare disease clinical trials. It will also highlight how by focusing on patient engagement, clinicians can both better understand patients’ needs and draw more meaningful research conclusions.</p> <p>First-Hand Account of a Rare Disease Patient<br /> Let’s start by understanding some of the struggles faced by those living with rare diseases. Medical student and rare disease patient Rebecca Nunn says mental health is a major concern for those with rare diseases.</p> <p>Indeed, in an open letter to the Orphanet Journal of Rare Diseases, Nunn notes that 69 percent of rare disease patients experience depression and 82 percent anxiety and stress. This is not surprising considering the often delayed diagnosis experienced by many people with rare conditions. Nunn’s disease took 17 years to be diagnosed correctly, and this after seeing numerous doctors throughout much of her life.</p> <p>Being accused of being a hypochondriac or diagnosed as having an untreatable anomaly, Nunn suffered for years. She says that many patients with rare diseases feel their healthcare professionals don’t trust or validate them, leading to their own mistrust of the healthcare providers.</p> <p>Added to this, it can be costly and time-consuming trying to diagnose and treat a rare disease and leaves patients feeling out of control of their lives. It’s important, then, that the clinical trial industry learn how to recruit, retain, engage and effectively treat these patients.</p> <p>Better Communication from the Outset<br /> Understanding patients and their language to enhance communication is crucial, advises Scott Schliebner, senior VP, Center for Rare Disease at PRA Health Sciences. The best way of doing this is by accessing bloggers, patient networks and advocacy websites to understand the words patients use to describe their conditions, symptoms and emotions. The goal is to find out how patients talk about healthcare providers and pharma companies and determine the challenges they face regarding their condition and past treatments.</p> <p>Schliebner also suggests using the “patient voice” to design the study. It will be challenging to translate patient feedback into study protocol, but is necessary for successful trials. Invite patients onto planning committees to provide insight in the same way as other important stakeholders do.</p> <p>network of faces representing the scope of rare disease clinical trials</p> <p>Online Patient Networks Are Influential<br /> Clinicians limited understanding of rare illnesses is a major concern, according to 3Sixty Pharma Solutions CEO Dalfoni Banerjee and Paul Burke, senior vice president at Chaucer Life Sciences. They say that even basic research into these conditions is limited as are diagnostic guidelines. The result of this lack of awareness is that patients living with rare diseases often experience a feeling of isolation.</p> <p>However, this isolation has resulted in the rise of many online communities, members of which are rare disease patients and their caregivers who are informed and engaged. Not only do these networks support patients, Banerjee and Burke argue that they exert influence over pharma companies, regulators and payers through their insights and personal knowledge helping pharma to shape orphan drug development programs and research agendas.</p> <p>The Added Recruitment Burden in Rare Disease Clinical Trials<br /> With a large number of children diagnosed with rare diseases, those who actually survive to adulthood will have experienced tremendous suffering.</p> <p>Patients with rare diseases will likely have spent a great deal of time being wrongly diagnosed, incorrectly evaluated and treated and have suffered from reduced quality of life as a result. More than that, they could well be nearing death.</p> <p>In these cases, patients are vulnerable and require a higher level of care than in other trials, which is why Michael F. Murphy, M.D., Ph.D., chief medical and scientific officer at Worldwide Clinical Trials, says recruitment and retention is especially important.</p> <p>Designing a trial protocol that acknowledges this is essential to keep patients engaged and committed to the trial. Patient-centric design, in which the patients’ experience of their disease is considered vital information, is even more important when it comes to studying rare diseases.</p> <p>For this reason, Murphy explains, trial managers and designers need to make participation as easy and informative as possible for patients.</p> <p>Strategies to Maximise Retention in Trials<br /> Patient-centricity is not just a buzzword but a real necessity to keep patients enrolled in rare disease trials, agrees Michelle Petersen, director of clinical operations at Medpace. This requires understanding the burden the study will place on patients and how to lighten it as well as determining appropriate endpoints and satisfying patients with the quality of treatment they receive.</p> <p>It also means, where possible, reducing the number of site visits by sending medication and homecare health practitioners to patients’ homes. Drug infusions, blood draws, PK sampling and minimally-invasive tests could be carried out there instead of requiring the patients to attend the site.</p> <p>Other important strategies for patient-centricity include a comprehensive risk/benefit profile and a clear consent form — perhaps in video format, which can be especially helpful for making procedures clear to pediatric patients. Also important but often forgotten is the duty of trial staff to provide comfort through helping patients access support network, counselling and organizing transport to advocacy meetings.</p> <p>Recruiting For Phase 3 Trials Are Particularly Challenging<br /> While the cost of running an orphan drug trial can be cheaper than non-orphan drugs because of its smaller sample size, it is much more challenging when it comes to recruitment, writes Samiya Luthfia Khaleel, senior research analyst at Beroe Inc.</p> <p>Approximately 30 percent of Phase 3 studies fail because of insufficient enrollment. The major factors impeding recruitment include the fact that more than 50 percent of rare diseases affect children, Khaleel says.</p> <p>And when patients are recruited, their participation is crucial, she adds. In a Phase 3 trial with 20-100 patients, for example, each patient is vital for evaluating the drug treatment and gathering data for the regulatory authorities and payers to determine pricing and reimbursement. Patient-centricity is key and should be considered when activating a trial site, Khaleel explains. For instance, where possible, prevalence of an illness should determine where a site is activated, instead of choosing multiple sites in various locations.</p> <p>The value here is lower costs and tighter timelines. However, fewer sites can mean longer travel for many patients. To counteract this, trial staff should ensure comfortable lodgings are provided and travel expenses reimbursed for patients, their caregivers and family members.</p> <p>Woman in a laboratory representing researchers working on rare disease clinical trials</p> <p>The Challenge of New Endpoints and Biomarkers<br /> With rare diseases, it can often be the case that researchers are investigating the condition for the first time. The consequence is that little is known about endpoints and biomarkers as they have not yet been validated, explains Han Phan, M.D., member of the FDA Pediatric Advisory Committee. This means researchers need to find new ways to test a treatment’s efficacy.</p> <p>Of course, supportive research and analysis can often provide sufficient assessment of efficacy, but not without risk of inaccuracy. Add to that the small number of patients experiencing the same illness and study results also run the risk of not being statistically significant.</p> <p>Patients are a wealth of information about their condition, Phan explains, so the patient voice can guide researchers and regulators in terms of understanding the balance between clinical trial results data and how treatment impacts patients’ health and quality of life.</p> <p>This is valuable when using new endpoints. Take the example of Duchenne Muscular Dystrophy (DMD) patients, Phan says. They may consider being able to use a restroom or eat a meal without assistance as a real success of treatment — a valuable insight to clinicians — even when a trial may miss a primary endpoint.</p> <p>Goal Attainment Scaling for Individualized Outcomes<br /> With rare diseases, finding more effective means of determining new endpoints is vital. This is why Kit C.B. Roes, professor of clinical trial methodology at the University Medical Centre, Utrecht in the Netherlands, argues for goal attainment scaling (GAS).</p> <p>To deal with possibly large variability between patients, GAS grants patients individualized outcomes that can still be summarized and compared within groups of patients to assess the effects of treatment.</p> <p>Consider how DMD sufferers have traditionally used the “six-minute walking test” as a default endpoint. Yet for boys with DMD, many become wheelchair-bound by the ages of eight to 10. The result is that many patients are excluded from trials because of failing this walking test.</p> <p>However, many would still benefit from treatment. This is where GAS, which focuses on individualized outcomes, can include more patients without threatening the study results, Roes explains.</p> <p>There’s an App for Rare Diseases<br /> With only 5 percent of qualified patients participating in trials and another 85 percent wanting to participate, Komathi Stem, biomedical engineer and founder of monARC Bionetworks, is hopeful that technology can change this.</p> <p>According to Stem, monARC is a smart health record technology that gathers patients’ medical records and, with a disease-specific app, allows patients to track symptoms between clinic visits. The aim is to simplify processes for patients to participate in trials — particularly remotely — and share data with researchers and family members.</p> <p>The added value, Stem says, is that pharmaceutical and device companies can rely on the data to determine the relevant endpoints.</p> <p>Rare diseases are a difficult clinical area to study, but it’s essential patients are effectively recruited, engaged and retained. Only through patient participation can researchers find answers to questions that have often plagued those living with rare diseases their whole lives.</p> </div> <ul class="cus_tags"><li ><a href="https://www.anjusoftware.com/tag/insights/" class="cus_tags_a">insights</a></li></ul> </div><!-- col --> </div><!-- row --> </main> <!-- #main --> </div><!-- #primary --> </div><!-- #content --> <!-- begin single blog page footer banner --> <div class="bg-blue-gradient blog-single-banner-bottom"> <div class="container text-md-center"> <h2 class="text-white">Want to stay up to date with our news? </h2> <a href="https://www.anjusoftware.com/newsletter-subscription/"><button class="btn btn-white">Want to stay up to date with our news?</button></a> </div> </div> <div class="related_post_slider"> <div class="container"> <h3 class="related_heading">Related Posts</h3> <div class="owl-carousel owl-theme mySwiper"> <div class="item"> <a href="https://www.anjusoftware.com/insights/eclinical/streamlining-clinical-trial-operations/"> <h5>Streamlining Clinical Trial Operations: How Integrated Technology Solutions Drive Efficiency</h5> </a> </div> <div class="item"> <a href="https://www.anjusoftware.com/insights/eclinical/esmo-2024-cancer-care-data-insights/"> <h5>ESMO 2024: Unlocking the Future of Cancer Care with Data-Driven Insights</h5> </a> </div> <div class="item"> <a href="https://www.anjusoftware.com/insights/eclinical/scdm-2024-innovation/"> <h5>Anju Showcases Innovation at 2024 SCDM Conference</h5> </a> </div> <div class="item"> <a href="https://www.anjusoftware.com/insights/data-science/technologies-clinical-trial-success-clinical-research-news/"> <h5>Leveraging Advanced Technologies for Clinical Trial Success</h5> </a> </div> <div class="item"> <a href="https://www.anjusoftware.com/insights/eclinical/clinical-trials-automation/"> <h5>Clinical Trials: How Automation is Reducing Time to Market</h5> </a> </div> <div class="item"> <a href="https://www.anjusoftware.com/insights/eclinical/clinical-trial-financial-management/"> <h5>Clinical Trial Financial Management: Strategies for Budgeting and Payments</h5> </a> </div> </div> </div> </div> <!-- <div class="related_post_slider"> <div class="row"> <h3 class="related_heading">Related Products</h3> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/streamlining-clinical-trial-operations/"><h5>Streamlining Clinical Trial Operations: How Integrated Technology Solutions Drive Efficiency</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/esmo-2024-cancer-care-data-insights/"><h5>ESMO 2024: Unlocking the Future of Cancer Care with Data-Driven Insights</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/scdm-2024-innovation/"><h5>Anju Showcases Innovation at 2024 SCDM Conference</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/data-science/technologies-clinical-trial-success-clinical-research-news/"><h5>Leveraging Advanced Technologies for Clinical Trial Success</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/clinical-trials-automation/"><h5>Clinical Trials: How Automation is Reducing Time to Market</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/clinical-trial-financial-management/"><h5>Clinical Trial Financial Management: Strategies for Budgeting and Payments</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/ai-clinical-research-clinical-trial-vanguard/"><h5>Exploring Digital Tech and AI in Clinical Research</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/data-integrity/"><h5>Data Integrity in Clinical Trials: The Role of Advanced EDC Systems</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/press-release/general-press-release/dia-2024-global-annual-meeting/"><h5>Anju Showcases Advanced eClinical Suite at DIA Global Annual Meeting 2024</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/patient-safety/"><h5>Protect Patient Safety in Early Phase Trials With eSource Solutions</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/streamlining-clinical-trials/"><h5>Streamlining Clinical Trials: The Impact of Automation in the Monitoring and Reporting Process</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/ta-scan-selected-by-leading-pharma-company-to-enhance-clinical-research/"><h5>Anju’s TA Scan Selected by Leading Pharma Company to Enhance Clinical Research</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/patient-centric-clinical-trials/"><h5>Patient-Centric Clinical Trials: Leveraging Technology for Enhanced Participant Engagement</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/fda-diversity-guidance/"><h5>Updated FDA Race and Diversity Guidance Open for Comments</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/patient-centricity-data-insights-outsourcing-pharma/"><h5>How Patient-Centricity is Becoming a Cliche and The Crucial Tool in Anju’s Arsenal</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/clinical-trial-costs/"><h5>Clinical Trial Costs Keep Rising: How to Fight Back</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/outsourcing-data-management/"><h5>Outsourcing Data Management in 2024: Challenges and Benefits</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/the-benefits-of-big-data-in-drug-development-contract-pharma/"><h5>The Benefits of Big Data in Drug Development</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/press-release/scope-2024-data-driven-strategies-clinical-research/"><h5>Anju Software Unveils Strategies for Data-Driven Decision-Making in Clinical Research at SCOPE Orlando 2024</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/patient-centric-care/"><h5>Time for Clinical Trials to Deliver on Patient-Centric Care Promises</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/the-importance-of-diversity-in-clinical-trials-clinical-research-news/"><h5>The Importance of Diversity in Clinical Trials: A Comprehensive Analysis</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/scope-orlando-2024/"><h5>SCOPE Orlando 2024: The Summit for Clinical Ops Executives</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/ismpp-europe-2024/"><h5>Conference Preview: ISMPP Europe 2024</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/data-management-challenges/"><h5>Overcoming Data Management Challenges in Self-Reporting Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-research/"><h5>Medical Research and Publishing Has Exploded: How Are You Managing Knowledge?</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/key-opinion-leaders/"><h5>Collaborating With Key Opinion Leaders in Early Clinical Trial Development: Navigating Risks and Rewards</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/medical-information/product-life-cycle/"><h5>How Medical Affairs Teams Can Optimize Product Life Cycle</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/press-releases/bioresearch-cro-partner/"><h5>Anju Welcomes Atherion Bioresearch as the Newest CRO Partner</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/data-compliance-and-harmonization/"><h5>Achieving Data Compliance in Decentralized Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/generative-ai/"><h5>Revolutionizing Clinical Research: The Role of Generative AI</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/ta-scan-global-diversity-data-best-of-show-award-winner-scope-europe-2023/"><h5>TA Scan’s Diversity Module Won Best of Show Award at SCOPE Europe 2023</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/clinical-trial-enrollment/"><h5>Community Pharmacies and Clinical Trial Enrollment</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/regulations-clinical-researchers/"><h5>The Regulations Clinical Researchers Should Track in 2024</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/all-news/eclinical-tradeshows/edc-eclinical-tradeshows/life-science-solutions-scdm-2023/"><h5>Anju Showcases Life Science Solutions at SCDM</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/scope-europe-2023/"><h5>SCOPE Europe 2023: 5 Unmissable Sessions and Insights for Clinical Operations Professionals</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/2023-dia-medical-information-conference/"><h5>Preview: 6 Sessions at DIA Medical Information Conference</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/compliance-auditing/"><h5>Clinical Trial Compliance Auditing: Challenges and Tools</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/umbrella-trials/"><h5>FDA Guidance on Umbrella Trials Can Help CROs Choose the Best Software</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/decentralized-trials/trialmaster-edc-solution-oncology-trials/"><h5>TrialMaster: The Right EDC Solution For Oncology Trials [White Paper]</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/site-visit-reports/"><h5>How Automated Site Visit Reports Improve Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/stakeholder-engagement/"><h5>How Medical Affairs Teams Can Boost Stakeholder Engagement</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/pharmaceutical-innovation/"><h5>How Patient Voices Power Pharmaceutical Innovation</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/rare-disease-clinical-trials-challenges/"><h5>Rare Disease Clinical Trials: Challenges and Opportunities Researchers Face</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/data-science/clinical-data-analysis/"><h5>Clinical Data Analysis: 3 Most Important Frontiers Right Now</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/fda-diversity-plan/"><h5>The FDA Race and Ethnicity Diversity Plan: How to Get Researchers Prepared</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/interview/eclinical-interview/edc-eclinical-interview/oncology-technology-clinical-trials/"><h5>Video Interview: Advancing Clinical Trials with Advanced Technology</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/disease-landscaping/"><h5>3 Tips to Perform a Disease Landscaping Analysis</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/alcoa-c-requirements/"><h5>eTMF for ALCOA-C Compliance in Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-publishing/"><h5>Medical Publishing: How the Right Tools Maximize Your Deliverable’s Reach</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/data-science/human-analysis-imperative-ai-data-management-clinical-leader/"><h5>Human Analysis Crucial in AI-Driven Data Management</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/data-science/asco-2023-insights-ta-scan/"><h5>Insights into the 2023 ASCO Annual Meeting</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/edc/reporting-adverse-events/"><h5>How To Improve the Process of Adverse Event Reporting</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/all-news/dia-masc-2023/"><h5>Our Most Anticipated Events at DIA MASC 2023</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/decentralized-trials/outsourcing-clinical-trials/"><h5>Outsourcing Clinical Trials: How to Build Successful Partnerships</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/all-news/data-science-tradeshows/ta-scan-data-science-tradeshows/opinion-leader-relationships/"><h5>Building Opinion Leader Relationships in a Post-Pandemic World</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/data-integration/"><h5>How the Right Tools Make Clinical Data Integration Seamless</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/ingishts/data/"><h5>You’ve Collected Your Medical Affairs Data. Now What?</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/ceo-laurence-birch-interview/"><h5>Laurence Birch Interview: Adaptive Life Sciences Tech</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/ingishts/automated-etms-tools/"><h5>Improve Clinical Trial Management With Automated eTMS Tools</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/press-releases/ta-scan-won-scope-best-of-show-award-2023/"><h5>TA Scan Won SCOPE Best of Show Award</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/decentralized-trials/future/"><h5>The Future of Decentralized Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/scope-2023-conference-preview/"><h5>SCOPE 2023 Conference Preview</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/configurability-and-customization-key-features-in-an-etmf-solution/"><h5>Configurability and Customization: Key Features in an eTMF Solution</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/digital-literacy-skills/"><h5>Why CRO Staff Need Robust Digital Literacy Skills</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/data-science/site-identification/ai-trial-research-questions-2/"><h5>Using AI to Formulate Clinical Trial Research Questions</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/measure-kol-engagement/"><h5>Tracking Relationships: Understanding KPIs That Measure KOL Engagement</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/etmf-platform/"><h5>Understanding Security and Role-Based Access in an eTMF Platform</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/edc/decentralized-trials-diverse-patients/"><h5>Decentralized Trials: Combating Bias and Reaching Diverse Patients</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/decentralized-trials/single-source-of-truth/"><h5>In a Data-Rich Landscape, a Single Source of Truth is Key</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/patient-centric-healthcare/"><h5>How Medical Affairs Teams Can Advocate for Patient-Centric Healthcare</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/ctms/clinical-trial-budgeting/"><h5>Accurate Clinical Trial Forecasting and Budgeting Strategies</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/patient-engagement/trial-participant-retention/"><h5>Retaining Trial Participants: Adherence and Dropout Mitigation</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/big-data-clinical-trials/"><h5>How Third Party Data Can Improve Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/edc/clinical-trial-metrics/"><h5>Discussing Clinical Trial Performance Metrics with Stakeholders</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/medical-information/combating-misinformation/"><h5>The Role of Medical Affairs in Combating Misinformation</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/kol/measuring-success/"><h5>Medical Affairs KPIs: How to Create a Framework For Measuring Success</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/data-science/clinical-trial-design/data-interoperability/"><h5>Data Interoperability and Sharing: Practical Considerations</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/edc/decentralized-trials-roles-and-needs/"><h5>Understanding Roles and Needs of Stakeholders in Decentralized Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/ingishts/kpis/"><h5>Top KPIs for Measuring Medical Affairs Success in 2022</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/data-science/automation-trial-monitoring/"><h5>Automation, Analytics, AI and the Future of Trial Monitoring</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/etmf/real-time-etmf-dashboard/"><h5>How a Real-Time eTMF Dashboard Helps Keep a Trial on Track</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/etmf/implementation-and-customization-of-etmf/"><h5>Ease of Implementation and Customization Spell eTMF Success</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/etmf/trialmaster-edc-gustave-roussy-cancer-research-business-trends-magazine-2022/"><h5>World-Class EDC for World-Class Cancer Research Center</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/edc/data-managers-skill/"><h5>5 Skills That Tomorrow’s Data Managers Will Need to Succeed</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/msl/medical-science-liaisons/"><h5>The Emerging Role of Medical Science Liaisons on Medical Affairs Teams</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/interview/eclinical-interview/edc-eclinical-interview/oncology-technology-clinical-trials-gustave-roussy-oncologytube/"><h5>Global Oncology Community Leveraging Technology for Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/kol/kols-are-key/"><h5>Understanding Which KOLs are Key for You</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/decentralized-trials/role-of-clinical-data-manager/"><h5>What Are The Responsibilities of a Clinical Data Manager and How Have They Evolved?</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/etmf/etmf-role-based-access/"><h5>Why Your eTMF Needs Role-Based Access</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/decentralized-trials/evp-mike-keens-applied-clinical-trials-podcast-june-2022/"><h5>Mike Keens on Clinical Trials Podcast</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/etmf/etmf-key-features/"><h5>What To Look For in an eTMF</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/etmf/etmf-digital-solution/"><h5>Why an eTMF? It’s Time for a Specialized Digital Solution</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/data-science/clinical-trial-design/world-ms-day-2022-tascan-data-analysis-clinical-research/"><h5>Data Analysis on Research for Multiple Sclerosis Day</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/international-clinical-trials/"><h5>Understanding Cross-Border Enrollment for International Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/data-science/ta-scan/chronic-obstructive-pulmonary-disease-latest-clinical-data-ta-scan/"><h5>Chronic Obstructive Pulmonary Disease: Latest Clinical Data</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/patient-engagement/reducing-patient-burden/"><h5>Lightening the Load: Reducing Patient Burden in Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/patient-engagement/patient-advocacy-groups/"><h5>Partnering with Patient Advocacy Groups Benefits Pharma and Patients</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/ai-oncology-research/"><h5>AI and Clinical Intelligence in Oncology Research</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/kol/machine-learning-and-kol-networks/"><h5>Machine Learning and KOL Networks: The Future of Medical Affairs</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/data-science/clinical-trial-design/world-parkinsons-day-2022-tascan-data-analysis-clinical-research/"><h5>Data Analysis on Latest Clinical Research for Parkinson’s Day</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/data-science/blockchain-for-clinical-trial-data/"><h5>Understanding the Value of Blockchain for Clinical Trial Data</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/patient-engagement/virtual-clinical-trials/"><h5>Benefits and Challenges in Virtual Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/data-privacy/clinical-trial-data-privacy/"><h5>Clinical Trial Data Privacy: What Trial Managers Need to Know</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/data-science/clinical-trial-design/disparate-data-sources/"><h5>Working With Disparate Data Sources To Improve Your Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/decentralized-trials/a-look-at-the-future-of-decentralized-trials-predictions-from-anju-softwares-evp-of-operations-mike-keens/"><h5>Future of Decentralized Trials: Anju EVP’s Predictions</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/data-science/feasibility/historical-data-clinical-trials/"><h5>How Historical Data and Controls Improve Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/publication-planning-medical-affairs/how-to-use-anju-softwares-pubstrat-max-to-better-promote-your-clinical-trial-and-therapy-performance-results/"><h5>Clinical Trial & Therapy Results: Anju’s Pubstrat MAX</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/ingishts/cybersecurity/"><h5>Impact of Cybersecurity and Data Privacy on Medical Affairs Teams</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/eucrof-2022-on-clinical-research/"><h5>6th European Clinical Research Conference: Presentations</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/overcoming-accessibility-challenges-in-international-clinical-trials/"><h5>Overcoming Accessibility Challenges in International Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/ai-clinical-trials/"><h5>How AI and Machine Learning Are Reshaping Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/clinical-data-ecosystem/"><h5>Managing Multiple Sources within the Clinical Data Ecosystem</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/medical-information/medical-information-call-centers/"><h5>The Post-Pandemic Future of Medical Information Call Centers</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/rtsm/clinical-trial-randomization/"><h5>Enhancing Trial Planning with Screening and Randomization</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/msl/medical-science-liaisons-data/"><h5>How To Empower Medical Science Liaisons With Data, and Why You Should</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/decentralized-trials/direct-to-patient-trials-2/"><h5>What Challenges Face Researchers With Direct-To-Patient Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/ingishts/crm/"><h5>Choosing a Medical Affairs CRM Platform: Key Considerations</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/kol/digital-opinion-leaders/"><h5>5 Strategies to Engage Digital Opinion Leaders</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/kol/digital-opinion-leaders-2/"><h5>Digital Opinion Leaders in Post-COVID Medical Affairs</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/edc/edc-software-features-2/"><h5>Getting the Most Out of Your EDC Software</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/decentralized-trials/tech-decentralized-clinical-trials/"><h5>How Technology is Moving Decentralized Clinical Trials Forward</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/data-privacy/hipaa-rule-changes/"><h5>Understanding HHS’ Proposed Rule Changes to HIPAA</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/edc/edc-decentralized-trials/"><h5>The Role of Electronic Data Capture in Decentralized Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/decentralized-trials/decentralized-clinical-trials-covid/"><h5>Decentralized Clinical Trials: Post-COVID Future</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/security-of-clinical-trial-data/"><h5>5 Ways to Improve the Security of Clinical Trial Data</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/decentralized-trials/cybersecurity-remote-clinical-trials/"><h5>Patient Privacy and Cybersecurity in Remote Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/data-privacy/clinical-data-cyberattacks/"><h5>Healthcare Cyberattacks and Clinical Data Management</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/clinical-quality-management/"><h5>Understanding Risk-Based Clinical Quality Management Technology</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/ingishts/anju-software-provides-adaptive-technology/"><h5>Anju’s Adaptive Tech Solutions for Clinical Trials and Medical Affairs</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/edc/edc-software-features/"><h5>The Benefits of Standardized, Machine-Readable Clinical Data</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/edc/clinical-oversight-solutions/"><h5>How to Use Clinical Oversight Solutions Effectively</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/data-science/clinical-trial-design/clinical-data-management-ai/"><h5>AI and ML in Clinical Data Management</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/data-science/clinical-trial-design/diverse-clinical-trials/"><h5>Diverse Clinical Trials: A Necessity for Personalized Medicine</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/medical-information/medical-information-distribution/"><h5>How to Measure the Effectiveness of Medical Information Distribution</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/data-science/data-collection-pandemic/"><h5>COVID-19’s Impact on Data Collection in Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/shorter-clinical-trials/"><h5>How More Data Can Lead to Shorter Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/decentralized-trials/early-stage-decentralized-clinical-trial-site-selection/"><h5>Early-Stage Decentralized Clinical Trial Site Selection: Key Factors</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/edc/accuracy-in-coding-for-clinical-trials/"><h5>How to Best Ensure Accuracy in Coding for Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/kol/medical-science-liaisons-and-key-opinion-leaders/"><h5>How Medical Science Liaisons Should Engage With Key Opinion Leaders</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/electronic-data-capture-software/"><h5>How Electronic Data Capture Software Facilitates Cleaner Trial Data</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/adaptive-systems-decentralized-trials/"><h5>Maximizing Decentralized Trials with Adaptive Systems</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/decentralized-trials/synthetic-data-early-phase-clinical-trials/"><h5>What is the Role of Synthetic Data in Early-Phase Clinical Trials?</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/publication-planning-medical-affairs/publication-planning/"><h5>Best Practices of Medical Affairs Publication Planning</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/edc/five-key-features/"><h5>What Five Key Features Should a Trial Director Look for in an EDC?</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/team-digital-communications/"><h5>How Medical Affairs Teams Can Improve Their Digital Communications</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/medical-information/irms-helps-medical-affairs/"><h5>4 Ways an IRMS Helps Medical Affairs Manage and Share Insights</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/cros-covid-19-vaccine-trials/"><h5>4 Lessons CROs Can Take Away From the COVID-19 Vaccine Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/early-phase-clinical-trials-changing/"><h5>Understanding the Changing Face of Early Phase Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/covid-19-vaccine-medical-affairs/"><h5>COVID-19 Vaccine’s Impact on the Role of Medical Affairs</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/ecosystem/"><h5>New Shifts In The Medical Affairs Ecosystem</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/cros-optimize-processes/"><h5>COVID-19 Vaccine Development Enables CROs to Optimize Processes</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/collaboration-opportunities/"><h5>Collaboration Opportunities Between Regulators and Medical Affairs</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/big-data/"><h5>How Big Data and AI Are Changing the Role of Medical Affairs & Pharma</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/data-privacy/data-protection-officers-clinical-trials/"><h5>CROs’ Guide to Data Protection Officers in Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/patient-engagement/decentralized-clinical-trials-recruitment/"><h5>Three Ways Decentralized Trials Bolster Patient Recruitment</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/pandemic-driven-medical-affairs/"><h5>Pandemic-Driven Medical Affairs and Scientific Insights Management</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/decentralized-trials/decentralized-trials/"><h5>The Continuing Rise of Decentralized Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/data-science/feasibility/solving-pharmas-data-dysfunction-conundrum/"><h5>How Do We Solve Pharma’s Data Dysfunction Conundrum?</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/medical-information/data-protection-in-medical-affairs/"><h5>Data Protection in Medical Affairs: Basic Cybersecurity</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/decentralized-trials/fda-clinical-trial-innovation/"><h5>FDA Guidance and Clinical Trial Innovation: Who’s Setting the Pace?</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/public-health-misinformation/"><h5>Public Health Misinformation: What Can Medical Affairs Teams Do?</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/edc/clinical-research-legal-questions/"><h5>Legal Questions Shaping Clinical Research</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/ingishts/support/"><h5>How Medical Affairs Can Support a Product Against New Competition</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/trust-building-strategies/"><h5>Trust-building in a Pandemic: Collaborative Strategies for MA teams</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/general/anju-innovation-forum-day-3-highlights/"><h5>Anju Innovation Forum Day 3 Highlights</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/general/anju-innovation-forum-day-2-highlights/"><h5>Anju Innovation Forum Day 2 Highlights</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/politics/"><h5>What Happens When Medical Affairs Intersects with Politics?</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/data-science/feasibility/international-research-collaboration/"><h5>International Research Collaboration: What Tools Can Help</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/the-mental-health-impact-of-covid-19-mental-health/"><h5>The Mental Health Impact of COVID-19 And How MA Teams Can Help</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/patient-engagement/manage-patient-fear/"><h5>How to Manage Patient Fear Regarding Clinical Trial Risks</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/leadership/"><h5>Building a Strong Foundation for Medical Affairs Leadership</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/etmf/clinical-trial-project-management/"><h5>Project Management Framework and Tools in Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/decentralized-trials/clear-accessible-science/"><h5>COVID-19: Clear, Accessible Science’s Importance</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/conferences-q4-2020/"><h5>10 Medical Affairs Conferences in Late 2020 and Early 2021</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/interview/join-dia-dtrial-forum-in-nanjing-to-hear-feng-cheng/"><h5>dTrial Forum in Nanjing, China hosts Feng Cheng as speaker</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/decentralized-trials/using-synthetic-data/"><h5>Insights on Using Synthetic Data for Clinical Trial Leaders</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/remote-professional-relationships/"><h5>Maintain Remote Professional Relationships: 3 Tips for Medical Affairs</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/covid-19-long-term-impact-on-trials/"><h5>How Will COVID-19 Impact Clinical Trials in the Long Term?</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/ingishts/patient-centric-rd/"><h5>Why Medical Affairs Must Lead a Patient-Centric Approach to R&D</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/pandemic-trial-leadership/"><h5>Research During a Pandemic: Trial Leadership Supporting Their Teams</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/covid-19/"><h5>Medical Affairs Leads COVID-19 Response</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/trial-participant-support/"><h5>What Extra Support Should Clinical Research Teams Offer Participants?</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/medical-information/accessible-medical-language/"><h5>Drug Labeling Trends: Making Language Accessible to Patients</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/patient-engagement/recruitment-incentives/"><h5>How Do Clinical Trial Recruitment Incentives Bias Research Outcomes?</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/medical-information/late-life-cycle-drugs/"><h5>5 Things Medical Affairs Can Do to Support Late Life Cycle Drugs</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/publication-planning-medical-affairs/publicizing-research/"><h5>Publicizing Research: Reach Audiences and Combat Misinformation</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/patient-engagement/nurse-navigators/"><h5>The Role of Nurse Navigators in Oncology Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/edc/the-importance-of-user-experience-in-life-sciences-software/"><h5>The Importance of User Experience in Life Sciences Software</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/coronavirus-medical-affairs/"><h5>COVID: The Role of Medical Affairs Teams in Public Health</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/data-science/site-identification/informed-site-selection-is-mission-critical-in-post-covid-19-era/"><h5>Informed Site Selection is Mission Critical in Post COVID-19 Era</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/clinical-research-covid-19/"><h5>The State of Clinical Research During the COVID-19 Pandemic</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/patient-engagement/awareness-campaigns/"><h5>Support for Awareness Campaigns: Good for Pharma and Patients</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/data-science/ta-scan/covid19update_may25/"><h5>Anju’s TA Scan Analysis of COVID-19 Update</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/patient-voice/"><h5>How Medical Affairs Can Amplify the Patient Voice</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/edc/the-right-tool-for-edc/"><h5>The Right Tool for EDC</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/value-based-clinical-trials/"><h5>Promoting Value-Based Clinical Trials in Medical Affairs</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/patient-engagement/social-media-clinical-trials/"><h5>How to Create Social Media Content to Engage Clinical Trials Patients</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/ma-teams-add-value/"><h5>Science Behind the Comms: How MA Teams Add Value to Messaging</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/virtual-trials/"><h5>Adaptations of Contract Research Organizations in Virtual Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/publication-planning-medical-affairs/catch_a_predator/"><h5>Uncovering Predatory Journals and Conferences: Best Practices</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/ingishts/marketing/"><h5>How Medical Affairs Can Support Pharma Marketing</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/patient-engagement/understanding-attrition/"><h5>Understanding Attrition: Gleaning Insights From Patients Who Quit</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/data-science/feasibility/global-clinical-trials-0/"><h5>Analysis performed by Anju via TA Scan on COVID-19</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/decentralized-trials/decentralized-clinical-trials/"><h5>Decentralized Trials: Bridging Distances in COVID-19</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/medical-information/credible-information/"><h5>Medical Affairs Provides Credible Consumer Information</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/edc/clinical-trial-design/"><h5>Avoiding 5 Pitfalls in Clinical Trial Design</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/clinical-trial-data-sharing/"><h5>Clinical Trial Data Sharing: Medical Affairs’ Role</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/direct-to-patient-trials/"><h5>When a Direct-to-Patient Trial Model Is the Right Choice</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/data-science/clinical-trial-design/systemic-biases/"><h5>How To Prevent Systemic Bias in Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/general/cro-conferences/"><h5>Top 2020 Conferences CROs Should Not Miss</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/conferences/"><h5>10 Global Medical Affairs Conferences to Attend in 2020</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/general/publication-planning/insights-from-ismpp-eu/"><h5>INSIGHTS from ISMPP EU</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/patient-engagement/global-clinical-trials/"><h5>Global Clinical Trials: Managing Patients and Meeting Compliance</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/patient-engagement/patient-centric-approach/"><h5>Patient-Centric Approach in Clinical Trial Design: Involve Patients Early</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/patient-engagement/patient-experience-officer/"><h5>Does Your Clinical Trial Need a Chief Patient Experience Officer?</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/medical-information/off-label-drugs/"><h5>How Medical Affairs Teams Can Help Get Off-Label Drugs to Patients</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/virtual-reality/"><h5>Virtual Reality in Clinical Research: Potential and Challenges</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/medical-information/medical-information-letters/"><h5>How Medical Affairs Can Use Tech to Provide Medical Information Letters</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/medical-information/insights-from-dia-2019-micc/"><h5>INSIGHTS from DIA 2019 MICC</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/data-science/clinical-trial-design/lifelong-illness/"><h5>Experimental Design: New Therapies Are Being Developed to Treat Lifelong Illness</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/edc/adaptive-design/"><h5>Best Practices for Managing Phase Transition in Adaptive Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/fda-483/"><h5>Understanding FDA 483: How To Run a Compliant Trial Every Time</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/brexit-clinical-trials/"><h5>Current Event Analysis: Brexit, Clinical Trials and Regulations</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/decentralized-trials/clinical-trial-ecosystem/"><h5>Changing Stakeholder Relationships in Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/decentralized-trials/clinical-data-exchange/"><h5>Automated Clinical Data Exchange for Collaboration in Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/patient-engagement/clinical-research-as-a-care-option/"><h5>Clinical Research as Care Option for Better Outcomes</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/patient-engagement/virtual-bedside-manner/"><h5>Enhancing Virtual Bedside Manner in Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/edc/evolution-of-clinical-trials/"><h5>Evolution of Clinical Trials: Faster Than Ever</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/ingishts/cbis-mpcf/"><h5>CBI’s Medical Publications Forum Insights</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/understanding-fda-expectations/"><h5>Evolving Needs for CROs: Understanding FDA Expectations</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/cro-benchmarking/"><h5>How CROs Benefit from Continual Improvement Analysis and Benchmarking</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/clinical-research-associates/"><h5>Attracting and Developing Clinical Research Associates</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/patient-engagement/primary-care-providers/"><h5>How to Engage Primary Care Providers in Clinical Trials and Connect With Patients Who Don’t Have Them</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/decentralized-trials/clinical-trial-ehrs/"><h5>Enhancing EHR Use for Efficient Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/patient-engagement/clinical-trial-under-enrollment/"><h5>Clinical Trial Under-Enrollment: How to Prevent It</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/patient-engagement/fih-clinical-trials/"><h5>Do No Harm: How to Mitigate Risk in Child and FIH Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/tech-skills-clinical-trial/"><h5>Tech Skills and Digital Natives in Demand as Clinical Trial Industry Evolves</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/patient-engagement/patient-advocates/"><h5>How to Foster Positive Relationships with Patient Advocates — and Why It’s Important</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/decentralized-trials/remote-monitoring/"><h5>More than Reduced Costs: The Benefits of Remote Monitoring in Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/edc/streamline-communication/"><h5>How Tech Can Streamline Communication Between Clinical Trial Sites, Sponsors and CROs</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/ctms/regulatory-submission-process/"><h5>How to Simplify the Clinical Trial Regulatory Submission Process</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/edc/cut-costs-clinical-trials/"><h5>Price Check: How to Cut Costs in Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/patient-engagement/post-trial-communication/"><h5>Patients as Partners: The Value of Post-Trial Communication</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/patient-engagement/clinical-trial-incentives/"><h5>Bias in Clinical Trial Incentives</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/epro/the-ugly-truth-about-paper-diaries/"><h5>The Ugly Truth About Paper Diaries</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/research-recruitment-firms/"><h5>Expert Hire: Profiles of 5 Top Clinical Research Recruitment Agencies</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/edc/integrative-medicine/"><h5>Is There a Place for Integrative Medicine Approaches in Clinical Trials?</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/ctms/adopting-new-technology/"><h5>What to Consider When Adopting New Technology in Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/precision-medicine/"><h5>Precision Medicine: Its Impact on Clinical Trials and Orphan Drugs</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/econsent-eclinical/21st-century-cures-act/"><h5>21st Century Cures Act and Informed Consent in Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/clinical-trial-trust/"><h5>How Clinical Trial Organizations Can Convey Trust and Credibility</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/unified-data-platform/"><h5>Unified Data Platform’s Impact on Clinical Trial Procedures</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/decentralized-trials/news-roundup-forbes-magazine-ranks-virtual-trials-as-a-top-five-digital-health-technology-trend/"><h5>Forbes Ranks Virtual Trials as a Top 5 Digital Health Technology Trend</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/data-science/clinical-trial-design/emerging-markets/"><h5>A Global Approach: Clinical Trials in Emerging Markets</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/ctms/ctms-best-practices/"><h5>How to Achieve CTMS Best Practices: Train Your Staff</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/data-science/achieving-transparency/"><h5>Achieving Transparency: Why and How to Share Trial Results Data</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/general/healthcare-it-conferences/"><h5>2019 Exhibitions and Events: Important Healthcare IT Conferences</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/data-science/clinical-trial-design/geriatric-research/"><h5>Geriatric Research: Why Your Study Should Include More Seniors</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/data-science/clinical-trial-design/women-in-clinical-trials/"><h5>Women’s Representation in Clinical Trials: Beyond Equality</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/ai-trial-research-questions/"><h5>The Next Step: Using AI to Formulate Clinical Trial Research Questions</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/data-science/feasibility/trial-eligibility-criteria/"><h5>Trial Eligibility Criteria: The Problem with Current Exclusion Strategies</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/ecoa/wearables-clinical-trials/"><h5>Voice Tech and Wearables’ Emerging Role in Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/mental-health-clinical-trials/"><h5>Mental Health Clinical Trials: Controversies, Challenges, Solutions</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/data-science/clinical-trial-design/time-management/"><h5>Why Time Management is Essential for Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/ctms/improve-site-selection/"><h5>How CTM Software Can Improve Site Selection For Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/edc/flexible-clinical-trial-design/"><h5>How to Build Flexible Clinical Trial Design — and How Software Can Help</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/edc/google-healthcare-data/"><h5>What Google’s Entrance Into Healthcare Data Means for Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/improving-site-relationships-for-efficient-trial/"><h5>How to Improve Trial Site Relationships for More Efficient Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/patient-engagement/technology-importance-for-patient-engagement/"><h5>Engagement and Adherence: How Technology is Keeping Trial Patients in the Loop</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/ctms/clinical-trial-reimbursement-for-patients-current-challenges-and-future-improvements/"><h5>Resolving Patient Reimbursement Challenges in Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/edc/overcoming-language-and-culture-barriers-in-multinational-clinical-trials/"><h5>Overcoming Language and Culture Barriers in Multinational Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/data-science/site-identification/increasing-diversity-with-trial-managers/"><h5>How Trial Managers Can Increase Diversity in Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/edc/anju-social-media-101-best-practices/"><h5>Social Media for Clinical Trial Recruitment</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/edc/the-anatomy-of-an-electronic-data-capture-system-edcs/"><h5>The Requirements of an Effective Electronic Data Capture System (EDCS)</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/improving-patient-retention-clinical-trials/"><h5>How to Improve Patient Retention in Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/edc/how-gdpr-is-affecting-clinical-trials/"><h5>How GDPR is Affecting Clinical Trials</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/decentralized-trials/how-to-create-an-effective-risk-based-monitoring-plan/"><h5>How to Create an Effective Risk-Based Monitoring Plan</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/decentralized-trials/how-risk-based-monitoring-can-improve-clinical-trial-operations/"><h5>How Risk-Based Monitoring Can Improve Clinical Trial Operations</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/edc/how-to-prepare-a-successful-nda-submission/"><h5>How to Prepare a Successful NDA Submission</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/medical-affairs/publication-planning-medical-affairs/researchers-whose-work-may-lead-to-cancer-treatment-breakthroughs/"><h5>Researchers Whose Work May Lead to Cancer Treatment Breakthroughs</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/designing-patient-friendly-trials/"><h5>Designing Patient-Friendly Trials for Site Performance</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/insights/eclinical/ecoa/10-reasons-emr-edc-integrations/"><h5>10 Reasons Why We Must Integrate EMR and EDC</h5></a> </div> <div class="col-md-4"> <a href="https://www.anjusoftware.com/interview/covid-19-transforms-the-clinical-trial-industry-ecosystem-industrywired/"><h5>COVID-19’s Transformation of the Clinical Trial Industry Ecosystem</h5></a> </div> </div> </div> --> <footer> <div class="bootscore-footer bg-light pt-5 pb-3"> <div class="container"> <!-- Top Footer Widget --> <div> <div class="footer_widget mb-5"><a href="https://prodanju.wpengine.com/"><img src="https://www.anjusoftware.com/wp-content/uploads/2023/01/anju-software-log.svg" class="image wp-image-2222 img-fluid attachment-full size-full" alt="" style="max-width: 100%; height: auto;" decoding="async" /></a></div> </div> <!-- Footer 1 Widget --> <div class="footer-wrapper"> <div class="row"> <div class="col-md-5"> <div class="location-pannel"> <div class="widget_text footer_widget mb-4"><h2 class="widget-title h4">Corporate Headquarters</h2><div class="textwidget custom-html-widget"><div class="footer-address"> <ul> <a href="https://www.google.com/maps/place/4343+Commerce+Ct+Ste+501,+Lisle,+IL+60532/@41.8070376,-88.1093637,17z/data=!3m1!4b1!4m6!3m5!1s0x880e56bf03c00001:0xc7bb7f67f7e904aa!8m2!3d41.8070336!4d-88.1067888!16s%2Fg%2F11mbn7zvb_?entry=ttu&g_ep=EgoyMDI0MDkwOC4wIKXMDSoASAFQAw%3D%3D" rel="noopener" target="_blank"><li><span class="text-blue-900">United States</span> Chicago, Illinois</li></a> <a href="https://www.google.com/maps/place/Uitbreidingstraat+86%2F2,+2600+Antwerpen,+Belgium/@51.1923177,4.416412,17z/data=!3m1!4b1!4m5!3m4!1s0x47c3f72679e87a2f:0x4e9ebae157c8a636!8m2!3d51.1923144!4d4.418606" rel="noopener" target="_blank"><li><span class="text-blue-900">European Union</span>Brussels, Belgium</li></a> <a href="https://www.google.be/maps/place/Anju+Life+Sciences+Private+Limited/@18.5338806,73.8254684,17z/data=!3m1!4b1!4m5!3m4!1s0x3bc2bf70da155555:0x20b08c5b99e6a8ad!8m2!3d18.5338755!4d73.8276624" rel="noopener" target="_blank"><li><span class="text-blue-900">Asia Pacific</span>Pune, India</li></a> </ul> </div></div></div><div class="widget_text footer_widget mb-4"><h2 class="widget-title h4">Follow us</h2><div class="textwidget custom-html-widget"><div class="footer_social_icon"> <a href="https://www.linkedin.com/company/anju-software/" target="_blank" rel="noopener"><img src="/wp-content/uploads/2022/12/linkdlin.svg" alt="linkedin"></a> <a href="https://twitter.com/AnjuSoftware" target="_blank" rel="noopener"> <img src="/wp-content/uploads/2024/09/X_Logo_Anju_Bluesmall.png" alt="Twitter"></a> </div></div></div> </div> </div> <div class="col-md-7"> <div class="links-pannel"> <div class="footer_widget mb-4"><h2 class="widget-title h4">Solutions</h2><div class="menu-solutions-footer-container"><ul id="menu-solutions-footer" class="menu"><li id="menu-item-108" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-108"><a href="https://www.anjusoftware.com/eclinical/">eClinical</a></li> <li id="menu-item-107" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-107"><a href="https://www.anjusoftware.com/medical-affairs/">Medical Affairs</a></li> <li id="menu-item-106" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-106"><a href="https://www.anjusoftware.com/data-science/">Data Science</a></li> </ul></div></div><div class="footer_widget mb-4"><h2 class="widget-title h4">Services</h2><div class="menu-services-footer-container"><ul id="menu-services-footer" class="menu"><li id="menu-item-110" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-110"><a href="https://www.anjusoftware.com/eclinical-services/">eClinical Services</a></li> <li id="menu-item-109" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-109"><a href="https://www.anjusoftware.com/medical-affairs-services/">Medical Affairs Services</a></li> <li id="menu-item-3839" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-3839"><a href="https://www.anjusoftware.com/data-science-services/">Data Science Services</a></li> </ul></div></div> <div class="footer_widget mb-4"><h2 class="widget-title h4">Technology</h2><div class="menu-technology-container"><ul id="menu-technology" class="menu"><li id="menu-item-111" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-111"><a href="https://www.anjusoftware.com/technology/">Technology</a></li> </ul></div></div><div class="footer_widget mb-4"><h2 class="widget-title h4">News & Events</h2><div class="menu-news-events-container"><ul id="menu-news-events" class="menu"><li id="menu-item-113" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-113"><a href="https://www.anjusoftware.com/insights/">Insights</a></li> <li id="menu-item-112" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-112"><a href="https://www.anjusoftware.com/press-releases/">Press Releases</a></li> <li id="menu-item-114" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-114"><a href="https://www.anjusoftware.com/events/">Events</a></li> </ul></div></div> <div class="footer_widget mb-4"><h2 class="widget-title h4">Company</h2><div class="menu-company-container"><ul id="menu-company" class="menu"><li id="menu-item-117" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-117"><a href="https://www.anjusoftware.com/about-anju/">About Anju</a></li> <li id="menu-item-116" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-116"><a href="https://www.anjusoftware.com/ingishts/management/">Management</a></li> <li id="menu-item-115" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-115"><a href="https://www.anjusoftware.com/careers/">Careers</a></li> </ul></div></div><div class="footer_widget mb-4"><h2 class="widget-title h4">Contact Us</h2><div class="menu-contact-us-container"><ul id="menu-contact-us" class="menu"><li id="menu-item-118" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-118"><a href="https://www.anjusoftware.com/request-a-demo/">Request A Demo</a></li> <li id="menu-item-119" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-119"><a href="https://www.anjusoftware.com/customer-support/">Contact Support</a></li> <li id="menu-item-126" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-126"><a href="https://www.anjusoftware.com/inquiries-locations/">Inquiries & Locations</a></li> </ul></div></div> </div> </div> </div> <!-- Footer Widgets End --> </div> <!-- Bootstrap 5 Nav Walker Footer Menu --> <!-- Bootstrap 5 Nav Walker Footer Menu End --> <div class="bootscore-info bg-light text-muted border-top text-center"> <div class="container"> <small class="start_text"><a href="https://anjusoftware.com/data-protection/" >Data Protection</a> | <a href="https://anjusoftware.com/privacy-policy/" >Privacy Policy</a> | <a href="/sitemap/" >Sitemap</a></small> <small class="end_text">©2023 All rights reserved</small> </div> </div> </div> </div> </footer> <!-- To top button --> <a href="#" class="btn btn-primary shadow top-button position-fixed zi-1020"><i class="fa-solid fa-chevron-up"></i><span class="visually-hidden-focusable">To top</span></a> </div><!-- #page --> <script type="text/javascript"> jQuery(document).on('click', ".cat_slug", function(e) { e.preventDefault(); var catSlug = jQuery(this).attr('data-slug'); console.log(catSlug); jQuery.ajax({ url: 'https://www.anjusoftware.com/wp-admin/admin-ajax.php', type: 'post', data: { action: 'data_fetch_insights', cat_slug: catSlug }, beforeSend: function() { // Show image container jQuery('.blog-append-here').html('Please Wait ...'); }, success: function(data) { if (data == "") { jQuery('.blog-append-here').html('<span class="d-block text-center text-danger">Sorry ...No Posts Found ...</span>'); } else { jQuery('.blog-append-here').html(data); } if (jQuery('ul').has(".page-numbers").length > 0) { jQuery('ul').removeClass('page-numbers'); jQuery('ul').addClass('press_release_page'); } } }); }); </script> <script type='text/javascript'> const lazyloadRunObserver = () => { const lazyloadBackgrounds = document.querySelectorAll( `.e-con.e-parent:not(.e-lazyloaded)` ); const lazyloadBackgroundObserver = new IntersectionObserver( ( entries ) => { entries.forEach( ( entry ) => { if ( entry.isIntersecting ) { let lazyloadBackground = entry.target; if( lazyloadBackground ) { lazyloadBackground.classList.add( 'e-lazyloaded' ); } lazyloadBackgroundObserver.unobserve( entry.target ); } }); }, { rootMargin: '200px 0px 200px 0px' } ); lazyloadBackgrounds.forEach( ( lazyloadBackground ) => { lazyloadBackgroundObserver.observe( lazyloadBackground ); } ); }; const events = [ 'DOMContentLoaded', 'elementor/lazyload/observe', ]; events.forEach( ( event ) => { document.addEventListener( event, lazyloadRunObserver ); } ); </script> <script> var footer = null; if(document.getElementsByTagName('footer')) { var footersTag = document.getElementsByTagName('footer') footer = footersTag[footersTag.length - 1]; } if (!footer){ footer = document.getElementById('footer'); } if(!footer) { var footersClass = document.getElementsByClassName('footer'); footer = footersClass[footersClass.length - 1]; } if (footer){ footer.insertAdjacentHTML('afterbegin', '<div class="be-ix-link-block"><div class="be-related-link-container container"><div class="be-label">Related Pages</div><ul class="be-list"><li class="be-list-item"><a class="be-related-link" href="https://www.anjusoftware.com/medical-affairs-services/">Depend on our experts to enhance your...</a></li><li class="be-list-item"><a class="be-related-link" href="https://www.anjusoftware.com/clinical-trial-data-sharing/">Clinical Trial Data Sharing: What Medical...</a></li><li class="be-list-item"><a class="be-related-link" href="https://www.anjusoftware.com/technology/">Technology that Scales with You</a></li></ul> </div></div>'); } </script><style id='global-styles-inline-css' type='text/css'> :root{--wp--preset--aspect-ratio--square: 1;--wp--preset--aspect-ratio--4-3: 4/3;--wp--preset--aspect-ratio--3-4: 3/4;--wp--preset--aspect-ratio--3-2: 3/2;--wp--preset--aspect-ratio--2-3: 2/3;--wp--preset--aspect-ratio--16-9: 16/9;--wp--preset--aspect-ratio--9-16: 9/16;--wp--preset--color--black: #000000;--wp--preset--color--cyan-bluish-gray: #abb8c3;--wp--preset--color--white: #ffffff;--wp--preset--color--pale-pink: #f78da7;--wp--preset--color--vivid-red: #cf2e2e;--wp--preset--color--luminous-vivid-orange: #ff6900;--wp--preset--color--luminous-vivid-amber: #fcb900;--wp--preset--color--light-green-cyan: #7bdcb5;--wp--preset--color--vivid-green-cyan: #00d084;--wp--preset--color--pale-cyan-blue: #8ed1fc;--wp--preset--color--vivid-cyan-blue: #0693e3;--wp--preset--color--vivid-purple: #9b51e0;--wp--preset--gradient--vivid-cyan-blue-to-vivid-purple: linear-gradient(135deg,rgba(6,147,227,1) 0%,rgb(155,81,224) 100%);--wp--preset--gradient--light-green-cyan-to-vivid-green-cyan: linear-gradient(135deg,rgb(122,220,180) 0%,rgb(0,208,130) 100%);--wp--preset--gradient--luminous-vivid-amber-to-luminous-vivid-orange: linear-gradient(135deg,rgba(252,185,0,1) 0%,rgba(255,105,0,1) 100%);--wp--preset--gradient--luminous-vivid-orange-to-vivid-red: linear-gradient(135deg,rgba(255,105,0,1) 0%,rgb(207,46,46) 100%);--wp--preset--gradient--very-light-gray-to-cyan-bluish-gray: linear-gradient(135deg,rgb(238,238,238) 0%,rgb(169,184,195) 100%);--wp--preset--gradient--cool-to-warm-spectrum: linear-gradient(135deg,rgb(74,234,220) 0%,rgb(151,120,209) 20%,rgb(207,42,186) 40%,rgb(238,44,130) 60%,rgb(251,105,98) 80%,rgb(254,248,76) 100%);--wp--preset--gradient--blush-light-purple: linear-gradient(135deg,rgb(255,206,236) 0%,rgb(152,150,240) 100%);--wp--preset--gradient--blush-bordeaux: linear-gradient(135deg,rgb(254,205,165) 0%,rgb(254,45,45) 50%,rgb(107,0,62) 100%);--wp--preset--gradient--luminous-dusk: linear-gradient(135deg,rgb(255,203,112) 0%,rgb(199,81,192) 50%,rgb(65,88,208) 100%);--wp--preset--gradient--pale-ocean: linear-gradient(135deg,rgb(255,245,203) 0%,rgb(182,227,212) 50%,rgb(51,167,181) 100%);--wp--preset--gradient--electric-grass: linear-gradient(135deg,rgb(202,248,128) 0%,rgb(113,206,126) 100%);--wp--preset--gradient--midnight: linear-gradient(135deg,rgb(2,3,129) 0%,rgb(40,116,252) 100%);--wp--preset--font-size--small: 13px;--wp--preset--font-size--medium: 20px;--wp--preset--font-size--large: 36px;--wp--preset--font-size--x-large: 42px;--wp--preset--spacing--20: 0.44rem;--wp--preset--spacing--30: 0.67rem;--wp--preset--spacing--40: 1rem;--wp--preset--spacing--50: 1.5rem;--wp--preset--spacing--60: 2.25rem;--wp--preset--spacing--70: 3.38rem;--wp--preset--spacing--80: 5.06rem;--wp--preset--shadow--natural: 6px 6px 9px rgba(0, 0, 0, 0.2);--wp--preset--shadow--deep: 12px 12px 50px rgba(0, 0, 0, 0.4);--wp--preset--shadow--sharp: 6px 6px 0px rgba(0, 0, 0, 0.2);--wp--preset--shadow--outlined: 6px 6px 0px -3px rgba(255, 255, 255, 1), 6px 6px rgba(0, 0, 0, 1);--wp--preset--shadow--crisp: 6px 6px 0px rgba(0, 0, 0, 1);}:where(.is-layout-flex){gap: 0.5em;}:where(.is-layout-grid){gap: 0.5em;}body .is-layout-flex{display: flex;}.is-layout-flex{flex-wrap: wrap;align-items: center;}.is-layout-flex > :is(*, div){margin: 0;}body .is-layout-grid{display: grid;}.is-layout-grid > :is(*, div){margin: 0;}:where(.wp-block-columns.is-layout-flex){gap: 2em;}:where(.wp-block-columns.is-layout-grid){gap: 2em;}:where(.wp-block-post-template.is-layout-flex){gap: 1.25em;}:where(.wp-block-post-template.is-layout-grid){gap: 1.25em;}.has-black-color{color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-color{color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-color{color: var(--wp--preset--color--white) !important;}.has-pale-pink-color{color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-color{color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-color{color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-color{color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-color{color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-color{color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-color{color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-color{color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-color{color: var(--wp--preset--color--vivid-purple) !important;}.has-black-background-color{background-color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-background-color{background-color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-background-color{background-color: var(--wp--preset--color--white) !important;}.has-pale-pink-background-color{background-color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-background-color{background-color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-background-color{background-color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-background-color{background-color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-background-color{background-color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-background-color{background-color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-background-color{background-color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-background-color{background-color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-background-color{background-color: var(--wp--preset--color--vivid-purple) !important;}.has-black-border-color{border-color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-border-color{border-color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-border-color{border-color: var(--wp--preset--color--white) !important;}.has-pale-pink-border-color{border-color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-border-color{border-color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-border-color{border-color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-border-color{border-color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-border-color{border-color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-border-color{border-color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-border-color{border-color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-border-color{border-color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-border-color{border-color: var(--wp--preset--color--vivid-purple) !important;}.has-vivid-cyan-blue-to-vivid-purple-gradient-background{background: var(--wp--preset--gradient--vivid-cyan-blue-to-vivid-purple) !important;}.has-light-green-cyan-to-vivid-green-cyan-gradient-background{background: var(--wp--preset--gradient--light-green-cyan-to-vivid-green-cyan) !important;}.has-luminous-vivid-amber-to-luminous-vivid-orange-gradient-background{background: var(--wp--preset--gradient--luminous-vivid-amber-to-luminous-vivid-orange) !important;}.has-luminous-vivid-orange-to-vivid-red-gradient-background{background: var(--wp--preset--gradient--luminous-vivid-orange-to-vivid-red) !important;}.has-very-light-gray-to-cyan-bluish-gray-gradient-background{background: var(--wp--preset--gradient--very-light-gray-to-cyan-bluish-gray) !important;}.has-cool-to-warm-spectrum-gradient-background{background: var(--wp--preset--gradient--cool-to-warm-spectrum) !important;}.has-blush-light-purple-gradient-background{background: var(--wp--preset--gradient--blush-light-purple) !important;}.has-blush-bordeaux-gradient-background{background: var(--wp--preset--gradient--blush-bordeaux) !important;}.has-luminous-dusk-gradient-background{background: var(--wp--preset--gradient--luminous-dusk) !important;}.has-pale-ocean-gradient-background{background: var(--wp--preset--gradient--pale-ocean) !important;}.has-electric-grass-gradient-background{background: var(--wp--preset--gradient--electric-grass) !important;}.has-midnight-gradient-background{background: var(--wp--preset--gradient--midnight) !important;}.has-small-font-size{font-size: var(--wp--preset--font-size--small) !important;}.has-medium-font-size{font-size: var(--wp--preset--font-size--medium) !important;}.has-large-font-size{font-size: var(--wp--preset--font-size--large) !important;}.has-x-large-font-size{font-size: var(--wp--preset--font-size--x-large) !important;} </style> <script type="text/javascript" src="https://www.anjusoftware.com/wp-includes/js/dist/hooks.min.js?ver=2810c76e705dd1a53b18" id="wp-hooks-js"></script> <script type="text/javascript" src="https://www.anjusoftware.com/wp-includes/js/dist/i18n.min.js?ver=5e580eb46a90c2b997e6" id="wp-i18n-js"></script> <script type="text/javascript" id="wp-i18n-js-after"> /* <![CDATA[ */ wp.i18n.setLocaleData( { 'text direction\u0004ltr': [ 'ltr' ] } ); /* ]]> */ </script> <script type="text/javascript" src="https://www.anjusoftware.com/wp-content/plugins/contact-form-7/includes/swv/js/index.js?ver=6.0" id="swv-js"></script> <script type="text/javascript" id="contact-form-7-js-before"> /* <![CDATA[ */ var wpcf7 = { "api": { "root": "https:\/\/www.anjusoftware.com\/wp-json\/", "namespace": "contact-form-7\/v1" }, "cached": 1 }; /* ]]> */ </script> <script type="text/javascript" src="https://www.anjusoftware.com/wp-content/plugins/contact-form-7/includes/js/index.js?ver=6.0" id="contact-form-7-js"></script> <script type="text/javascript" src="https://www.anjusoftware.com/wp-content/themes/bootscore-child-main/assets/js/owl.js?ver=1.0" id="mcs_local_owl_js-js"></script> <script type="text/javascript" src="https://www.anjusoftware.com/wp-content/themes/bootscore-child-main/assets/js/custom.js?ver=1.0" id="mcs_main_script-js"></script> <script type="text/javascript" src="https://www.anjusoftware.com/wp-content/themes/bootscore-child-main/assets/js/p2.js?ver=1.000002" id="p2_scripts-js"></script> <script type="text/javascript" src="https://www.anjusoftware.com/wp-content/themes/bootscore-main/js/lib/bootstrap.bundle.min.js?ver=202301272028" id="bootstrap-js"></script> <script type="text/javascript" id="bootscore-script-js-extra"> /* <![CDATA[ */ var bootscore = {"ie_title":"Internet Explorer detected","ie_limited_functionality":"This website will offer limited functionality in this browser.","ie_modern_browsers_1":"Please use a modern and secure web browser like","ie_modern_browsers_2":" <a href=\"https:\/\/www.mozilla.org\/firefox\/\" target=\"_blank\">Mozilla Firefox<\/a>, <a href=\"https:\/\/www.google.com\/chrome\/\" target=\"_blank\">Google Chrome<\/a>, <a href=\"https:\/\/www.opera.com\/\" target=\"_blank\">Opera<\/a> ","ie_modern_browsers_3":"or","ie_modern_browsers_4":" <a href=\"https:\/\/www.microsoft.com\/edge\" target=\"_blank\">Microsoft Edge<\/a> ","ie_modern_browsers_5":"to display this site correctly."}; /* ]]> */ </script> <script type="text/javascript" src="https://www.anjusoftware.com/wp-content/themes/bootscore-main/js/theme.js?ver=202301272028" id="bootscore-script-js"></script> <script type="text/javascript" id="heateor_sss_sharing_js-js-before"> /* <![CDATA[ */ function heateorSssLoadEvent(e) {var t=window.onload;if (typeof window.onload!="function") {window.onload=e}else{window.onload=function() {t();e()}}}; var heateorSssSharingAjaxUrl = 'https://www.anjusoftware.com/wp-admin/admin-ajax.php', heateorSssCloseIconPath = 'https://www.anjusoftware.com/wp-content/plugins/sassy-social-share/public/../images/close.png', heateorSssPluginIconPath = 'https://www.anjusoftware.com/wp-content/plugins/sassy-social-share/public/../images/logo.png', heateorSssHorizontalSharingCountEnable = 0, heateorSssVerticalSharingCountEnable = 0, heateorSssSharingOffset = -10; var heateorSssMobileStickySharingEnabled = 0;var heateorSssCopyLinkMessage = "Link copied.";var heateorSssUrlCountFetched = [], heateorSssSharesText = 'Shares', heateorSssShareText = 'Share';function heateorSssPopup(e) {window.open(e,"popUpWindow","height=400,width=600,left=400,top=100,resizable,scrollbars,toolbar=0,personalbar=0,menubar=no,location=no,directories=no,status")} /* ]]> */ </script> <script type="text/javascript" src="https://www.anjusoftware.com/wp-content/plugins/sassy-social-share/public/js/sassy-social-share-public.js?ver=3.3.70" id="heateor_sss_sharing_js-js"></script> <script type="text/javascript" src="https://www.google.com/recaptcha/api.js?render=acsa&ver=3.0" id="google-recaptcha-js"></script> <script type="text/javascript" src="https://www.anjusoftware.com/wp-includes/js/dist/vendor/wp-polyfill.min.js?ver=3.15.0" id="wp-polyfill-js"></script> <script type="text/javascript" id="wpcf7-recaptcha-js-before"> /* <![CDATA[ */ var wpcf7_recaptcha = { "sitekey": "acsa", "actions": { "homepage": "homepage", "contactform": "contactform" } }; /* ]]> */ </script> <script type="text/javascript" src="https://www.anjusoftware.com/wp-content/plugins/contact-form-7/modules/recaptcha/index.js?ver=6.0" id="wpcf7-recaptcha-js"></script> <script type="text/javascript" src="https://www.anjusoftware.com/wp-content/plugins/google-site-kit/dist/assets/js/googlesitekit-events-provider-contact-form-7-21cf1c445673c649970d.js" id="googlesitekit-events-provider-contact-form-7-js" defer></script> <!-- be_ixf, sdk, is --> <script> try { //For tracking on the page https://www.anjusoftware.com/request-a-demo/ parent.postMessage('request_demo_form_submitted', 'https://www.anjusoftware.com'); } catch(e) { // Something went wrong window.console && window.console.log(e); } try { //For tracking on the page https://www.anjusoftware.com/inquiries-locations/ parent.postMessage('inquiries_locations_form_submitted', 'https://www.anjusoftware.com'); } catch(e) { // Something went wrong window.console && window.console.log(e); } try { //For tracking on the page https://www.anjusoftware.com/newsletter-subscription/ parent.postMessage('subscription_form_submitted', 'https://www.anjusoftware.com'); } catch(e) { // Something went wrong… window.console && window.console.log(e); } </script> </body> </html>